• Author Index
• Abstract Index
• Search
• Journal Homepage
• ISTH Homepage
• Online Journal
• Privacy Policy
• 2003
• 2005
• 2007
• 2009

Author Index

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

 

B
B George	-	Thirty Novel Mutations in the Factor VIII Gene of Indian Patients with Haemophilia A
Baba Y	-	Standardization of Assays for Plasma Fibrin-Fibrinogen Degradation Products
Babinska A	-	The Platelet/Endothelial Cell Adhesion Protein F11R (a.k.a. JAM-1) Is Present in Cerebral Blood Vessels, Meninges, the Choroid Plexus and on Neuronal Cells
	-	Phosphorylation of the Extracellular Domain of the F11R/JAM-1 and Its Role in Platelet Aggregation
Babinska A	-	Evidence of a Critical Role for F11R (a.k.a. JAM-1) in the Adhesion of Platelets to the Endothelium at the Onset of Inflammatory Thrombosis
Babyn P	-	Results from the Canadian Hemophilia Dose Escalation Prophylaxis Trial: An Update
Bach J	-	Gene Polymorphisms of Hemostasis And Lipid Metabolism in Apparently Healthy Individuals from Southwest Germany
	-	Monitoring of Heparinization during Extracorporeal Circulation (ECC) with the New Anti-Factor Xa (FXa) Point-of-Care (POC) Clotting Assay Heptest-POC-Hi™
Bach J	-	Factor VIII Activity and Antigen, VWF and ABO-Genotype Are Not Associated with Coronary Heart Disease
Bacher P	-	Nitric Oxide Levels Are Elevated in Patients with Malignancy Associated Hypercoagulable State
Bacheschi L	-	Sticky Platelet Syndrome Is a Cause of Cerebral Venous Thrombosis
Bachoo P	-	Evaluation of Aspirin Resistance in Peripheral Arterial Disease
Badenhorst PN	-	A Model of Femoral Arterial Stenosis to Evaluate Anti-platelet Drugs in Baboons
Bader R	-	The Factor VIII/von Willebrand Factor Antigen (FVIII/VWF : Ag) Ratio in Determining VWF Defects in Patients with von Willebrand Disease Type 1: Results from the European Multicenter MCMDM-1VWD Study
Badereddine L	-	Haemophilia B in Female
Badimon L	-	Statins Prevent the Increase of Tissue Factor Activity and Microparticle Release Induced by Aggregated LDL in Human Vascular Smooth Muscle Cells
Badlou BA	-	Metabolic Arrest Suppresses Platelet Binding to and Phagocytosis by Macrophages
Badol P	-	Effect of Thiosulfinates on Calpain and the Platelet Release Machinery
Bækgaard N	-	Catheter Directed Thrombolysis of Acute Iliofemoral Deep Venous Thrombosis Is Effective and Preserves Venous Valve Function. Results from a Prospective One-centre Study of 60 Cases
	-	Congenital Aplasia of the Inferior Vena Cava Is a Major Risk Factor for Iliofemoral Deep Venous Thrombosis. A Prospective One-centre Study of 50 Cases
Baert J	-	False Positives Account For Low Conversion Frequency In Chimeraplasty For Von Willebrand Disease
Baffour R	-	Transendocardial Autologous Bone Marrow Cell Transplantation in Patients with Advanced Ischemic Heart Disease – A Multi-Center Feasibility Study
Bagan-Triquenot A	-	Protein Z Polymorphisms and Cerebral Venous Thrombosis
Baggio MS	-	Influence of ABO Blood Group on the Collagen-Binding Assay
	-	Retrospective and Prospective Analysis of the Incidence of Venous Thromboembolism in First-Degree Relatives of Factor V Leiden and Factor II G20210A Carriers
Baghaei F	-	Case Report on Successful Use of Activated Prothrombincomplex Concentrate FEIBA® in Orthopedic Surgery on Two Patients with Factor VIII Inhibitors
Baghaei F	-	Long-term Prophylaxis in VWD. The Swedish Experience
Baghaipoor MR	-	Mutation Analysis of the Factor VIII Gene in 224 Iranian Families with Haemophilia A
Baghaipour MR	-	Dental Procedure Using Recombinant Activated Factor VII (Novo Seven) in 22 Patients with Platelet Function Disorder in Iran
Baghli L	-	Haemophilia B in Female
Baglia FA	-	Fine Mapping of the Prothrombin Binding Site in the Apple 1 Domain of Factor XI
	-	Glycoprotein Ib-IX-V Complex Mediates Localization of Alpha-thrombin to Lipid Rafts on the Platelet Membrane
Baglin T	-	New Insights into Heparin Binding and Activation of Heparin Cofactor II
Bagot C	-	Prospective Study of the Diagnosis of Pulmonary Embolism (PE) Using Pretest Probability (PTP), D-Dimer (DD) and Appropriate Imaging
Bahnson BJ	-	Crystal Structure of Calcium- and Integrin-Binding Protein 1: Insights to a Novel Mechanism of Action
Bahou WF	-	Platelets Express Steroidogenic 17b–hydroxysteroid Dehydrogenases: Distinct Profiles Predict the Essential Thrombocythemic Phenotype
Bahou W	-	PAR3 Expression and Functions Studied with Blocking, Cleavage Site-Specific Antibodies
Bahr W	-	Early Anticoagulation for Prevention and Therapy of Deep Venous Thrombosis In Patients Undergoing Craniotomy For Brain Tumor – Risk of Postoperative Intra-cranial Hemorrhage in a Prospective Long-term Study
Bahr W	-	Perioperative Prophylaxis Against Thromboembolism in Patients Undergoing Craniotomy for Brain Tumor: Analysis of Efficacy of Early Low Molecular Weight Heparin
Bahram Z	-	Thromboembolic Disease and Its Relationship with ABO-Rh Blood-Groups and Other Variables in Patients at Warfarin Clinics in Iran
Bahri A	-	Antiphospholipid Syndrome and Risk of Myocardial Infarction in Young: A Preliminary Study
Bai X	-	Imaging Experimental Pulmonary Embolism in Dogs Using 99mTc-Llabeled SZ51-F(ab)2
Bai X	-	Expression of Tissue Factor Pathway Inhibitor-2 by Retrovirus and Its Effects in Rat Glioma Cells Migration and Invasion
Bai X	-	Clinical Relevance of Expression of VEGF-C and Its Receptors in Patients with Chronic Myelogenous Leukemia
	-	A Monoclonal Antibody Against Platelet GPVI Impaires the Interaction Between Platelet and Collagen
	-	Clinical Relevance of Expression of VEGF-C and Its Receptors IN Patients with Chronic Myelogenous Leukemia
Bai Y	-	Strong Lupus Anticoagulant (LA) Appears to Interfere with Activated Protein C Resistance Assay (APCR)
Bai X	-	Hereditary Plasminogen Activator Inhibitor-1 Deficiency Related to Ala15Thr Mutation in Its Signal Peptide
	-	Construction of a Phage Display Library of Human Fab Antibodies against Human Platelet Membrane Glycoprotein IIb/IIIa
	-	The Clinical Significance of Matrix Metalloproteinases Production by Bone Marrow Mononuclear Cells from Patients with Chronic Myeloid Leukemia
	-	Atorvastatin Delays Thrombus Formation and Inhibits Leukocyte-Firm Adhesion to Thrombi Following Laser-Induced Arterial Injury in the Mouse
	-	Identification of Two Novel Mutations in ADAMTS13 Gene in A Pregnant Patient with Congenital Thrombotic Thrombocytopenic Purpura
Bai X	-	A2 Domain of Human Von Willebrand Factor Expressed in E. Coli and Its Use in Quantitative Measurement of ADAMTS13 Activity
Baik N	-	Plasminogen Inhibits Monocyte Apoptosis
Bailey KR	-	Risk Factors for Venous Thromboembolism (VTE) Among Patients Hospitalized for Major Surgery: A Population-Based Case-Control Study
	-	Risk Factors for Venous Thromboembolism (VTE) among Patients Hospitalized for Acute Medical Illness: A Population-Based Case-Control Study
Baird TR	-	Prothrombin Colocalizes to the Platelet Thrombus and Vessel Wall Interface after Laser Induced Thrombosis Injury
	-	Factor XI Deficient Mice Have Reduced Platelet Accumulation and Fibrin Deposition after Laser Injury
Baird TR	-	Prothrombin Fragment 1 and Annexin V Localize Differently after Laser Induced Vascular Injury in vivo
Bajaj SP	-	Role of Residue 193 in Development of the Oxyanion Hole in Serine Proteases: Kinetic Studies of the Effect of Side Chain Length and Charge in Factor XIa
	-	Role of Residue 192 in Development of the Oxyanion Hole and in Macromolecular Specificity in Serine Proteases: Importance of Lys554 (192 in Chymotrypsin Numbering) in Factor XIa Catalysis
Bajaj Jr. SP	-	Role of Gamma-Carboxyglutamic Acid (Gla) and First Epidermal Growth Factor (EGF1)-Like Domains of Factor IX (FIX) in Physiologic Coagulation
Bajc M	-	Home Treatment in Pulmonary Embolism
Bajusz S	-	Protective Effects of GYKI-66476 and GYKI-66430 in Experimental Models of Disseminated Intravascular Coagulation (DIC)
Bajzar L	-	Activated Carboxypeptidase N Is a Potent Antifibrinolytic Agent in Human Plasma
Baker R	-	Platelet Activation in Whole Blood, Red Cell Concentrates and Whole Blood Derived Platelet Concentrates
Baker J	-	PKCalpha Coordinates Syk and Src Signalling in Human Platelets
Baker R	-	Hormonal Regulation of the Anticoagulant Protein S
	-	Anticoagulant Adverse Events in a Major City Hospital
Baker RI	-	Protein Z Gene Polymorphisms, Protein Z Concentration and Ischaemic Stroke
Bakhtiari K	-	Endotoxemia Induces Factor VIII-mediated Resistance to Activated Protein C in Healthy Humans
Baklan TN	-	Enhancement of Catalytic Activities of Thrombin and Trypsin By Human Insulin
Bal dit Sollier C	-	A Multi-Rule Expert System to Manage OAT in Most Real-Life Clinical Situations
	-	The Predictive Value of D-Dimers on the Occurrence of Thromboembolic Events and Death: A Prospective Multicentric Study
	-	We Still Need to Organize French Anticoagulation Clinics
	-	Usefulness of Platelet VASP Quantification to Monitor Antiplatelet Treatment by Thienopyridines
	-	Interaction between Paracetamol and Warfarin: A Double-Blind Placebo-Controlled Randomised Study
Balark K	-	Leukemia after P32 Radionuclide Synovectomy for Hemophilic Arthropathy
Balbale S	-	Circulating Inhibitor in an Elderly Female That Impairs the Action of Human But Not Rabbit Brain Thromboplastin
Balci D	-	The Correlation among Tissue Factor Pathway, Endothelial Damage Parameters and Lipid Profile in Children with Type 1 Diabetes Mellitus
Baldan N	-	Long-Term Treatment with High-Dose Recombinant Human Antithrombin does not Prevent Acute Humoral Rejection in Primate Recipients of Porcine Xenografts
Baldi M	-	Influence of the Enos Gene Polymorphisms on the Homocysteine Plasma Levels in Healthy Subjects
Baldi G	-	Determinants of Mortality in Cerebral Hemorrhage Patients on Antithrombotic Treatment: Prospective Evaluation in the Italian Emergency Departments of a Multicentric Cohort of 1071 Patients
Baldoni M	-	Host-Drug Interaction: The Influence of Small Intestinal Bacterial Overgrowth on Oral Anticoagulant Dose Requirement
Balducci D	-	ADAMTS-13 Activity Profile in Thrombotic Thrombocytopenic Purpura (TTP) Patients Prospectively Followed At A Single Centre
	-	Parallel Changes in Procoagulant Activity and Proangiogenic Capacity of Breast Cancer and Leukaemia Cells Exposed to All Trans Retinoic Acid (ATRA)
Balduini CL	-	Platelets Morphological and Functional Characterisation in a Novel Case of Grey Platelet Syndrome: Defective Response to Thrombin, PAR1-AP And PAR4-AP and Correlation with Alpha-Granules Content in the Patient and Four Relatives
Balduini A	-	Both Haploinsufficiency and Dominant Negative Effect Are Responsible for Hematological Abnormalities of Patients with -Related Disease
Balduini CL	-	Both Haploinsufficiency and Dominant Negative Effect Are Responsible for Hematological Abnormalities of Patients with -Related Disease
Baldwin M	-	Molecular Pathways for Lymphangiogenesis and Their Role in Human Disease
Balgojevich E	-	Thrombophilia Is Frequent in Superficial Vein Thrombosis and Is Associated with Recurrence: A Retrospective Study
Ball D	-	The Effects of Surgery on Platelet and Endothelial Function in Patients with Peripheral Arterial Disease and Severe Limb Ischaemia
	-	The Effects of Isometric and Treadmill Exercise on Platelet and Endothelial Function in Patients with Intermittent Claudication
Ballarino GJ	-	Clinical Audit of Thromboembolism Prophylaxis 3 years after the 6th ACCP Report in a Tertiary Care Hospital in Córdoba, Argentina
Balmer C	-	Congenital Prothrombotic Disorders in Children with Venous and Arterial Thrombosis
Balogh E	-	Factor XIII Levels and Factor XIII a Subunit Val34Leu Polymorphism in Patients with Coronary Sclerosis and Myocardial Infarction
Balogh I	-	Analysis of Gas6 in Human Platelets and Plasma
Balogh I	-	A Novel Homozygous Mutation (1619delC) in GPIIb Gene Associated with Glanzmann Thrombasthenia, the Decay of GPIIb-mRNA and the Synthesis of a Truncated GPIIb Unable to Form Complex with GPIIIa
	-	Three Novel Missense Mutations and Their Functional Consequences in Two Severe Inherited Factor X Deficiencies
Baltrukovich N	-	Refolding Characteristics of Recombinant Beta3(109-352) Fragment and Formation of a Functionally Active A-Domain
Banait V	-	Thrombophilia Markers in Cases of Inflammatory Bowel Disease (IBD)
Bandinelli S	-	Vitamin B6 Serum Level and Inflammation and in the InChianti Study
Bandinelli B	-	MTHFR C677T Polymorphism is Associated with Low Levels of Folic Acid in the InChianti Study
Bandinelli S	-	Inflammatory Markers are Associated with the Abdominal Aortic Diameter
Bandinelli B	-	Interaction of Choline/Betaine Metabolysm and Homocysteine Plasma Levels
	-	Managed Hemostasis ‘Point-Of-Care’ Testing in a Large Hospital: A Three-Year Experience and the Assessment of Clotting Tests
Banerjee P	-	Phosphorylation of the Extracellular Domain of the F11R/JAM-1 and Its Role in Platelet Aggregation
Banerjee Y	-	A Novel Anticoagulant Protein – Hemextin A, from the Venom of Hemachatus Haemachatus (African Ringhals Cobra) That inhibits the Extrinsic Tenase Activity and Its Synergistic Interaction with A Three-finger Toxin, Hemextin B
Bang KWA	-	The Effect of Coronary Distal Embolisation on Myocardial Blood Flow and Platelet Activation
Bang KWA	-	Clearance of Procoagulant Platelet-Derived Microparticles from the Circulation of Rabbits
Bank I	-	Platelets Promote CD4+ Lymphocyte Adhesion to Extracellular Matrix and Fibronectin Under Flow: Role of Integrins, CD40 Ligand and P-Selectin Glycoprotein Ligand-1
	-	A Prospective Cohort Study of Asymptomatic Individuals with Elevated Factor VIII : c to Determine the Absolute Incidence of Venous and Arterial Thromboembolism
Banks J	-	The Impact of Acquired Thrombophilia on Maternal and Fetal Wellbeing in a Low-risk Population
Bannink L	-	Increased Risk of Venous Thrombosis after Orthopedic and General Surgery. Results of the MEGA Study
Banno F	-	Generation and Characterization of ADAMTS13-Deficient Mice
Bannon PG	-	Heparin Selectively Inhibits CD11b High Affinity Neo-epitope Expression in vivo During Coronary Artery Bypass Surgery
Bansal V	-	Tissue Factor, Thrombomodulin and P-Selectin Levels Are Increased in End Stage Renal Disease
	-	Upregulation of Inflammatory Mediators in ESRD Patients: Pathophysiologic Implications
Bansal K	-	Robustness Testing of OPTIVATE® Intermediate Purification Stages
Bansal V	-	Protein Chip Array Profiles in End Stage Renal Disease (ESRD) Patients
Banzet N	-	Circulating Endothelial Cell Count as a Diagnostic Marker for Non-ST Elevation Acute Coronary Syndromes
Bao C-X	-	Alteration of Protein Z in Cardio-Cerebra Thrombotic Diseases and Its Significance
	-	Alteration of Protein Z in Patients with Uremia and Its Significance
Baomin X	-	Evaluation of a Novel Direct Factor VIIa Inhibitor in Rabbit Models of Arterial Thrombosis and Hemostasis
Barabás É	-	Protective Effects of GYKI-66476 and GYKI-66430 in Experimental Models of Disseminated Intravascular Coagulation (DIC)
Barakat W	-	Combined Deficiency of Factor V and Factor VIII: Compound Heterozygosity For Two Novel Truncating Mutations in ERGIC53/LMAN1
Baranska P	-	Thalidomide Affects Early Phases of VEGF Stimulated Angiogenesis in Human Endothelial Cells
Barbanti M	-	Parnaparin Prevents Platelet-PMN Leukocyte Interaction: New Clues to the Antithrombotic Properties of Low Molecular Weight Heparin
	-	Parnaparin Prevents the Upregulation of Platelet-Leukocyte Interaction in Whole Blood
Barbaux S	-	Functional Role of Human P-Selectin (CD62P) Polymorphisms in Mediating Cell-Cell Interactions
Barbe MF	-	A Synthetic Peptide Derived From Thrombospondin-1 (TSP1) Type 3 Repeats Modulates Angiogenesis and the Disease Course in an Animal Model of Rheumatoid Arthritis (RA) by Down-Regulating Connective Tissue Growth Factor (CTGF) Expression
Barber HK	-	O-GlcNAc Cycling Is Important for Regulated Platelet Exocytosis
Barbui T	-	Parallel Changes in Procoagulant Activity and Proangiogenic Capacity of Breast Cancer and Leukaemia Cells Exposed to All Trans Retinoic Acid (ATRA)
	-	Clinical Significance o IgG and IgM Anti-Phospholipid (aPL), Anti-Beta2-Glycoprotein I (aBeta2GPI), and Anti-Prothrombin (aPT) Antibodies: Retrospective and Prospective Analysis of the WAPS Study
	-	ADAMTS-13 Activity Profile in Thrombotic Thrombocytopenic Purpura (TTP) Patients Prospectively Followed At A Single Centre
	-	Testing for Anticardiolipin Antibodies and Anti-Beta2-Glycoprotein I. Is It Useful? A Scientist's Perspective
	-	Prevalence and Clinical Significance of IgG and IgM Anti-Protein S (aPS) and Anti-Annexin V (aAV): Retrospective and Prospective Analysis of the WAPS Study
Barbulescu DM	-	Kinetics of Factor VIII Assays in Mild Haemophilia A: Implications for Choice of Diagnostic Assay
Barden A	-	Enhanced Antiplatelet Effect of Clopidogrel in Patients with Aspirin Resistance: A Randomized Crossover Trial
Bardet V	-	Molecular Basis of MYH9-Related Disorders in a Series of Ten Families
Bardin N	-	Anti-Protein S and Anti-Phosphatidylethanolamine (aPE) Antibodies in Patients with Clinical Features of Antiphospholipid Syndrome (APS)
	-	Soluble CD146 in Women with Unexplained Pregnancy Loss: A New Insight. A Paired Case–Control Study
Bárdos H	-	Three Novel Missense Mutations and Their Functional Consequences in Two Severe Inherited Factor X Deficiencies
Bareford D	-	Plasma Levels of Tissue Factor and Soluble E-Selectin in Sickle Cell Disease: Relationship to Genotype and to Inflammation
Barek L	-	Functional Role of Human P-Selectin (CD62P) Polymorphisms in Mediating Cell-Cell Interactions
Barellier MT	-	Interactions between Prothrombotic Mutations and Hormone Therapy in Relation to the Risk of Venous Thromboembolism: Impact of the Route of Estrogen Administration
Bari S	-	Comparative Effects of Nitroxil (HNO) and NO on Platelet Function and Tyrosine Phosphorilation Pattern of Activated Human Platelets
Barillari G	-	Clinical and Molecular Characterization of Three Italian Patients with Severe Factor V Deficiency and Bleeding Disorder (‘Parahaemophilia’): Report of a Novel Homozygous Mutation (FV: Asp524His)
	-	Pharmacokinetics, Efficacy and Safety of Solvent/Detergent (S/D) Treated Plasma in Patients with Rare Inherited Coagulation Disorders (RICDs)
Barker RN	-	Altered Clearance of Apoptotic Endothelial Cells in the Presence of Antiphospholipid Antibodies Provides a Dual Mechanism for Thrombosis in Antiphospholipid Syndrome
Barnard D	-	The Canadian Hemophilia Outcomes-Kids Life Assessment Tool (CHO-KLAT): Results of the Reliability and Validation Study
Barnard MR	-	Increased Platelet Activation in Cystic Fibrosis: A Role for cAMP/Adenylate Cyclase But Not for Mead Acid or Platelet CFTR
	-	Preconditioning Ischemia Favorably Attenuates Platelet Activation: Insights into Molecular Mechanisms
	-	A Novel Mechanism of Action of Clopidogrel: Inhibition of Monocyte Procoagulant Activity
	-	Clinical ‘Aspirin Resistance’ Is Associated with Increased Cyclooxygenase-Independent Platelet Activation
	-	Pre-Existent Variability in Platelet Response to ADP Accounts FOR ‘Clopidogrel Resistance’
Barnard D	-	A Comparison of the Canadian Hemophilia Outcomes – Kids Life Assessment Tool (CHO-KLAT) and the HaemoQoL
Barnes C	-	Clotting Factor Prophylaxis in Boys with Haemophilia; Experience from a Single Australian Centre
Barnes KD	-	Inactivation of the Human Platelet cGMP-Induced cAMP Phosphodiesterase (PDE3A) by Affinity Labeling of an Octapeptide in the Unique 44 Amino Acid Flexible Loop
Barnes E	-	Generation of Kininogen Deficient Mice
Barnes C	-	Multi Modal Management of Purpura Fulminans due to Homozygous Protein C Deficiency
	-	Chromogenic and Clot Based Protein C Assays Contribute to the Management Of Homozygous Protein C Deficient Patients
	-	Incidence of Major Bleeding in a Large Paediatric Cohort of Patients Requiring Warfarin Therapy
Barni S	-	The G1691A Factor V and G20210A Prothrombin Gene Mutations Are Not Associated to an Increased Risk of Venous Thromboembolism (VTE) in Patients with Gastrointestinal (GI) Carcinoma
Baron DW	-	The Activation of Intracoronary Monocytes and Platelets Correlates with Cardiac Enzyme Levels in Patients Undergoing Coronary Artery Stenting
Baronciani L	-	Mutation Profile in Patients Diagnosed with Type 1 von Willebrand Disease in the European Study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD)
Baroni M	-	Natural Mutations in the 4th EGF-Like Domain of Protein S Alter GLA and SHBG Domain Interactions
Barral FG	-	Clinical Experience with Retrievable ALN Vena Cava Filters
Barrellier MT	-	Hormone Therapy and Venous Thromboembolism among Postmenopausal Women: Impact of the Route of Estrogen Administration and Progestogens
Barrett NE	-	Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1) Negatively Influences Thrombus Formation in Vivo
Barrett B	-	Preliminary Results of a Cross-Sectional Study of Mild Hemophilia A in Newfoundland and Labrador, Canada
Barro C	-	Intracerabral Hematoma and Congenital Afibrinogenemia
	-	Bilateral Ankle Prosthesis in a Severe Von Willebrand Disease Patient under Substitutive Wilfactin Treatment
Barrow RT	-	Characterization of Anti-Human and Anti-Porcine Factor VIII Monoclonal Antibodies Produced by Hemophilia A Mice
Barrowcliffe TW	-	Could Haemostasis in Haemophilia A Be Normalised by Factor VIII (FVIII) Concentrates at Levels below 1 IU/mL? Studies with Various Methods of Thrombin Generation
	-	Comparison of the Procoagulant Activity of T-Lymphoblastoid Cells with Fresh Platelets in Three Phospholipid Dependent Assays
Barrowcliffe TW	-	A Multi-centre Assessment of the Chromogenic Method for Factor VIII:C Estimation in Plasma-derived and Recombinant Concentrates
Barsom A	-	Aspirin Induces Receptor Shedding in Platelets by TNFa–Converting Enzyme (TACE)
Barsukov A	-	The Role of Low Doses Anti-TNF In Improvement of Immune Function in PAD Patients after Late Thrombosis
Barteling W	-	Laboratory Identification of Severe Haemophilia Is APTT-Reagent Dependent
Baruch D	-	Enhanced Shear-Induced Platelet Aggregation in Patients Who Experienced Subacute Stent Thrombosis: A Case-Control Study
	-	Combination of Loss of Function of Recombinant R1334A-VWF and Gain of Function of R1336A-VWF Results in a Loss of Function of RKR1334-1335-1336A-VWF
	-	Slower Translocation of Platelets at High Shear Rate without Increased Calcium Signals on Type 2B Recombinant Von Willebrand Factor
	-	Increased outside-in Signaling and Adhesive Functions under Shear Conditions of Cells Expressing the aIIbb3T562N Integrin
Bashiruddin J	-	The Relationship Between Hypercoagulable State and Sudden Sensory Neural Deafness
Basileo M	-	Absence of Interaction Between Influenza Vaccination and Oral Anticoagulant Therapy: A Randomized Blinded Clinical Trial
Basili S	-	Insulin Resistance and Platelet Activation in Obese Women
	-	Hypercoagulability May Predict Embryo Implantation after Assisted Reproductive Procedures
Baskova I	-	Microvessel Hemostasis Is Inhibited by Medicinal Leech Salivary Gland Secretion
Bass H	-	Usefulness of a Particle Gel Immunoassay (PaGIA) for Rapid Diagnosis of Heparin-Induced Thrombocytopenia
Bassi A	-	Thromboelastography Is a Useful Predictor of Stent Thrombosis
Bassitt R	-	Sticky Platelet Syndrome Is a Cause of Cerebral Venous Thrombosis
Bassitte RP	-	Treatment of Extensive Venous Malformation-Associated Localized Intravascular Coagulation with Interferon-Alpha: Case Report
Bassler N	-	Polymorphisms Known to Increase the Risk of Atherothrombosis Do Not Affect the Risk of Thrombembolism as Determined in Patients with Atrial Fibrillation
	-	A Unique Fusion Protein Combines Clot Targeting, Platelet Blockade and Direct Factor Xa Inhibition in One Molecule
	-	Selenium Causes Decreased Rolling and Adhesion of Monocytes under Venous Flow Conditions Via Shedding of L-Selectin (CD62L)
	-	Design of Small Molecular Weight Activation-specific GPIIb/IIIa Inhibitors Based on the CDR3 Region of a Phage Display-derived Single-chain Antibody
	-	Targeting of the Direct FXa Inhibitor TAP via the Fusion of a Single-chain Antibody Directed Against a LIBS Epitope on GPIIb/IIIa Provides Effective Anticoagulation without Bleeding Time Prolongation
	-	Superparamagnetic Iron Oxide Uptake as Imaged By Magnetic Resonance Is Mediated by the Integrin Receptor MAC-1 (CD11b/CD18) – Possible Implications on Imaging of Atherosclerotic Plaques
Bassus S	-	Tissue Factor Efficacy in Patients with Severe Hemophilia a Undergoing Total Knee Replacement
	-	Individual Efficacy Measurement of FVIII Replacement Therapy in Cell-based Monitoring Tests
Bassus S	-	Effect of Beer, Dealcoholized Beer and Ethanol Consumption on Hemostasis in Humans
Basta G	-	N-3 Polyunsaturated Fatty Acids Selectively Affect Circulating Microparticle Subpopulations in Patients with Myocardial Infarction
Bastelica D	-	Lipopolysaccharide-Induced Endotoxemia in the Mouse is Aggravated by PAI-1 Overexpression
	-	Polymorphism A36G of the Tumor Necrosis Factor Receptor 1 Gene Is Associated with HDL Cholesterol, TNFR1 and PAI-1 Levels in Obese Women
Bastida E	-	Successful Immune Tolerance Induction in a High-Responding Factor VIII Inhibitor Hemophilia a Patient Treated with FVIII/VWF Plasma-Derived Concentrate, Fanhdi®. Cost Effectiveness Analysis
Bastien O	-	MIP-1b and VE-Cadherin Are Implicated in Acute Rejection in Human Heart Transplantation
Bastos M	-	Monocytes and Plasma Tissue Factor Levels in Normal Individuals and Patients with Lower-Limbs Deep Venous Thrombosis: Potential Diagnostic Tools?
Batchelor AJ	-	Hypobaric Hypoxia Reduces Thrombus Formation Rate Measured by Thromboelastography
	-	Hypobaric Hypoxia Does Not Influence Markers of Coagulation, Platelet, Endothelial or Fibrinolytic Activation
Bateman RM	-	Imaging of Highly Organized Vitronectin-Vimentin Polymeric Complexes that Express on the Surface of Activated Platelets and Platelet Microparticles using Atomic Force Microscopy
	-	Chimeric PAI-1-dsRed Fusion Protein Characterization and Expression in MEG-01 Megakaryocytic Cells: Model for PAI-1 Trafficking from a-Granules to Cell Surfaces
Bateman RM	-	The Effect of Thrombin Concentration on Fibrin Clot Structure Imaged by Multiphoton Microscopy and Quantified by Fractal Analysis
Bates SM	-	Evaluation of the Relationship between Free Protein S Levels and Thrombin Generation during Pregnancy
	-	New Anticoagulants
Bates E	-	Dose-Dependent Clopidogrel-Atorvastatin Drug–Drug Interaction Determined by Light Transmission Aggregometry
Bates I	-	Satisfaction and Safety of Two Domiciliary Anticoagulation Services for Mobility-impaired Patients: Preliminary Trial Findings
Bates E	-	Cyclosporine Reduces the Platelet Inhibitory Effect of Clopidogrel in Cardiac Transplant Patients
Bates SM	-	Derivation of a Clinical Model to Predict the Likelihood of Recurrent Deep Vein Thrombosis
Bath PMW	-	Effects of Granulocyte-Colony Stimulating Factor on Platelet and Leukocyte Function in Whole Blood in vitro
Batista IFC	-	Amblyomma Cajennense Tick: The Transcriptome, Expression and Biochemical Characterization of a Factor Xa Recombinant Inhibitor
Batlle A	-	Vein Trombosis in Pediatric Patients
Batlle J	-	Association of FVIII/Von Willebrand Factor Measurements and PFA-100® with Bleeding Score in Type 1 Von Willebrand Disease (VWD) Families. The MCMDM-1 Study
	-	Assay of the von Willebrand Factor Propeptide (VWFpp) to Identify Type 1 von Willebrand Disease (VWD) Patients with a Decreased von Willebrand Factor (VWF) Survival Phenotype
	-	The Incidence and Penetrance of Common VWF Gene Mutations in a Cohort of Type 1 VWD Patients: Results from the EU Funded MCMDM-1VWD Project
	-	The Factor VIII/von Willebrand Factor Antigen (FVIII/VWF : Ag) Ratio in Determining VWF Defects in Patients with von Willebrand Disease Type 1: Results from the European Multicenter MCMDM-1VWD Study
	-	Multimer Pattern in Patients Diagnosed with Type 1 von Willebrand Disease in the European Study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD)
	-	Abnormal Multimeric Pattern Is Not Associated with Increased Bleeding Symptoms in Index Cases of Families with Type 1 VWD. Results from the EU MCMDM-1 VWD Study
	-	Two Novel Type 1 Von Willebrand Disease Causing Mutations (G160W and N166I) in the Von Willebrand Factor Propeptide, Identified in the European Study MCMDM-1VWD, Are Responsible for Multimerization And Secretion Defects
	-	Responsiveness to Desmopressin: Influence of Genotype in Patients Diagnosed with Type 1 von Willebrand Disease in the European Study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD
	-	Mutation Profile in Patients Diagnosed with Type 1 von Willebrand Disease in the European Study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD)
	-	Cysteine Mutations in the von Willebrand Factor D3 Domain Correlate with Multimerization Defects in Patients Previously Diagnosed with von Willebrand Disease Type 1 in Patients Entered in the European Multicentre Study MCMDM-1VWD
	-	Linkage Analysis of von Willebrand Disease Type 1 Phenotype, von Willebrand Factor Levels and Bleeding Symptoms with Von Willebrand Factor Gene Locus in the European Multicenter MCMDM-1VWD Study
	-	Oral Anticoagulant Treatment (OAT) with Portable PT Monitor in Primary Health Care Centres with Immediate Dose Adjustment by the Hospital OAT Unit
	-	Analysis of Bleeding Score in Type 1 VWD Families in the MCMDM-1 Study
	-	Collagen Binding (VWF : CB) Is Less Sensitive Than Ristocetin Cofactor Activity (VWF : RCo) in Suggesting Von Willebrand Factor (VWF) Molecular Defects in Patients with Von Willebrand Disease Type 1: Results From the European Multicenter MCMDM-1VWD Study
Batora I	-	Hyperbaric Oxygen Therapy in Chronic Non-Healing Diabetic and Venous Ulcer
Batorova A	-	Hyperbaric Oxygen Therapy in Chronic Non-Healing Diabetic and Venous Ulcer
Batorova A	-	Gynaecological Problems in Severe Congenital Factor VII Deficiency
Batorova A	-	Factor X Deficiency: Clinical Manifestation of 102 Subjects with Mutations in Factor 10 Gene
Batorova A	-	Genetic and Phenotypic Analysis of Families with Inherited Hypo- and Dys-fibrinogenemia
Batorova A	-	Heterozygosity for a Novel FGG Trp253Cys Mutation Causes Hypofibrinogenemia by Specifically Impairing Fibrinogen Secretion
Battaglioli T	-	Risk Factors for Thrombophilia in Extra-Hepatic Portal Vein Obstruction
	-	Antithrombotic Porphylaxis During Pregnancy in Women with Previous Venous Thromboembolism
Battistella PA	-	Cerebral Sinovenous Thrombosis in Children
Battiston M	-	Von Willebrand Factor-Mediated Platelet Adhesion in Flowing Blood is Influenced by Hematocrit
	-	Integrin a2b1 and Glycoprotein VI Dependent Calcium Signals in Platelets Interacting with Acid-Soluble Type I Collagen Under Flow
Battle J	-	In vitro Expression of Ten Missense Mutations in the VWF C-Terminal Domain Identified in Patients Diagnosed with Type 1 VWD: Results from the MCMDM-1VWD Study
	-	A Reduced VWF to FVIII Binding Capacity is not Uncommon in Patients With Type 1 Von Willebrand Disease: Results From the MCMDM-1VWD Study
Battler A	-	Transendocardial Autologous Bone Marrow Cell Transplantation in Patients with Advanced Ischemic Heart Disease – A Multi-Center Feasibility Study
Baud F	-	Prolonged Extracorporeal Life Support (ECLS) in Patients with Severe Membrane Stabilizing Agent (MSA) Poisonings: Hemostatic Management Requires only Minimal Doses of Heparin
Baudo F	-	The EACH Registry: A Prospective European Registry of Acquired Haemophilia (AH)
	-	Management of the Patients on Long Term Oral Anticoagulant Treatment (OAT) Undergoing Elective Surgery: Experience of the Italian Anticoagulation Clinics
Baudo F	-	Automated VWF : RCo for VWD Diagnosis
Baudry O	-	Evaluation of PAI-1 Inhibitors in the Microcirculation of the Hamster Cheek Pouch
Bauduer F	-	Identification and Characterization of 10 Novel Mutations Causing Factor XI Deficiency
Bauer K	-	An Oral, Direct Factor Xa Inhibitor – BAY 59-7939 – for Prophylaxis against Venous Thromboembolism after Total Knee Replacement: A Dose-ranging Study
Bauer KA	-	Activation of the Contact Factor System and Its Predictive Role in Coronary Heart Disease and Ischemic Stroke; Follow Up from the Second Northwick Park Heart Study
Bauer M	-	Podoplanin-Induced Platelet Aggregation is Responsible For Separation of Blood and Sprouting Lymphatic Vessels during Embryonic Development
Bauer KA	-	The Benefit-to-Risk Ratio of Fondaparinux Thromboprophylaxis in Patients Undergoing Major Orthopedic Surgery Is Independent of Age
Bauer JS	-	A Novel Method for Determination of Human Plasma Plasminogen Activator Inhibitor (PAI-1)
Bauer K	-	Fondaparinux Combined with Intermittent Pneumatic Compression (IPC) Versus IPC Alone in the Prevention of VTE after Major Abdominal Surgery: Results of the APOLLO Study
Bauersachs J	-	Inhibition of Platelet Activation in Diabetic Rats by Chronic Treatment with the Guanylyl Cyclase Activator HMR1766
Bauersachs R	-	Intravenous Leiomyosarcoma Presenting As Iliac Vein Thrombosis
Bauersachs J	-	Fractalkine Mediates Leukocyte Recruitment to Inflammatory Endothelial Cells in Flowing Whole Blood
	-	Inhibition of Platelet Activation in Rats with Severe Congestive Heart Failure by Treatment with an Endothelial NO-Synthase Enhancer
Bauersachs RM	-	Safety and Efficacy of Low-Molecular-Weight Heparin (Dalteparin) in Pregnant Women at Increased Risk of Venous Thromboembolism: A Prospective Stratified Multicentre Trial
Bauersachs R	-	Rebound after Discontinuation of Long-term Oral Anticoagulation (OAC): Effects of a 4 week Course of LMWH on VTE Recurrences
Bauersachs J	-	Rosuvastatin Reduces Platelet Activation in Heart Failure: Role of Nitric Oxide Bioavailability
Bauman M	-	KIDCLOT (Kids Informed Decrease Complications: Learning On Thrombosis) ©
Bauman J	-	Barriers to Appropriate Anticoagulation with Warfarin in Orthopedic Surgery
Bauman M	-	Incorporation of a Comprehensive Pediatric Thrombosis Program as Part of the Multidisciplinary Care Team for Children with Congenital Heart Disease: A Prospective Cohort Study
Baumbach GA	-	Supplemental Alpha-2-Antiplasmin Prevents Plasmin-Induced Hemorrhage
Baumgartner B	-	Kinetics of in vivo Activation of Protein C In Healthy Animals
Bauters A	-	Influence of 10 Polymorphisms Located in Genes Coding for Factors Involved in Coagulation and Fibrinolysis on the Risk of Venous Thrombosis in Factor V Leiden Homozygotes: Study of 233 Subjects
Baxi SM	-	Paradoxical Example of Warfarin Exerting Anti-Thrombotic Effect without Significantly Altering Template Bleeding Times in Rabbits
Baxter J	-	Neonatal Thrombophilia: Novel Findings Related to the Red Cell Membrane and Red Cell-Endothelial Adhesion
Bazzan M	-	Duration of Anticoagulant Treatment and Recurrence of Venous Thromboembolism in Patients with and without Thrombophilia
	-	Prevalence of Thrombophilic Abnormalities in Patients with Deep Vein Thrombosis or Pulmonary Embolism
	-	Risk Factors for CVC-Associated Thrombosis in Cancer Patients: Analysis of the ETHIC Study
Beard M	-	A High Prevalence of Ankle Arthropathy in Mild and Moderate Haemophilia A in South Australia and a Threshold Effect of FVIII Level on Its Occurrence
Beardsley DS	-	Protein Tyrosine Kinase, Syk, Involved in Immune Platelet Phagocytosis, Also Plays a Role in Human Macrophage Cell-Cell Interactions and PECAM-1 Mediated Signal Transduction
Beaudin S	-	Modulation of Monocyte Function by Activated Protein C, a Natural Anticoagulant
	-	Effect of Chemotherapeutic Agents on the Protein C Anticoagulant Pathway
Beaulieu LM	-	Role of the Protein C System in Endothelial and Breast Cancer Cell Migration
Beaulieu JF	-	The Relationship Between INR Time-In-Range and Risk of Stroke and Major Bleeds in Chronic Non-Valvular Atrial Fibrillation Warfarin Utilizers
Beaune P	-	A Mutation in Vitamin K Epoxide Reductase Complex Subunit-1 (VKORC1) in a Patient with Vitamin K Antagonist Resistance
Beauregard P	-	The Whole Blood Platelets Aggregation Test for HIT Diagnosis
Becanovic J	-	The Platelet Actin Cytoskeleton Dynamically Reorganizes into Podosomes Upon Cell Adhesion. Identification of a Novel Actin-rich Adhesive Structure in Human Platelets
Becattini C	-	High Incidence of Bilateral Deep Vein Thrombosis in Cancer Patients
	-	Low-Dose Aspirin for Secondary Prophylaxis of Vein Thrombosis – A Prospectively Planned Meta-Analysis
Becattini C	-	Prevalence of Thrombophilic Abnormalities in Patients with Deep Vein Thrombosis or Pulmonary Embolism
Becattini C	-	Duration of Anticoagulant Treatment and Recurrence of Venous Thromboembolism in Patients with and without Thrombophilia
Beck DO	-	The Cofactor Effect of the B Domain Of Coagulation Factor V on Factor Va Inactivation by Activated Protein C
Becka M	-	Effect of Enoxaparin on the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BAY 59-7939 – an Oral, Direct Factor Xa Inhibitor
	-	Aspirin Has No Effect on the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BAY 59–7939 – An Oral, Direct Factor Xa Inhibitor
Becker S	-	Both, COP I and COP II Coatomers Are Involved in the Anterograde ER to Golgi Transport of B-domain Deleted FVIII
Becker S	-	Antiphospholipid Antibodies in Children – Reference Values in Healthy Controls and Frequency in Children with aPTT Prolongation, Thrombosis or Stroke
Beckmann MW	-	The G20210A Prothrombin Gene Mutation and the Plasminogen Activator Inhibitor (PAI) 5G/5G Genotype Increase the Risk of Premature Onset of Severe Preeclampsia
Beconcini S	-	Clotting Profile by Sonoclot Analysis Is Different in Patients Undergoing Off-Pump and On-Pump Coronary-Artery Bypass Surgery
	-	Protein Z Decreases During Follow-up of Patients with Acute Coronary Syndromes
Becton DL	-	Use of FEIBA for Surgical Procedures in Patients with Severe Hemophilia A and B and Inhibitors
	-	Prophylaxis with Factor Eight Inhibitor Bypassing Activity, Vapor Heated (FEIBA VH) Decreases Bleeding Frequency and Maintains or Improves Joint Status
Bedard PW	-	A Novel P-Selectin Inhibitor, PSI-697, Demonstrates Positive Activity Following Oral Administration in Rodent Models of Vascular Inflammation
Bedard P	-	Prophylaxis using a Novel Oral Small Molecule Inhibitor to the P-selectin Receptor Promotes Thrombus Resolution in a Baboon Model of Venous Thrombosis
	-	WAY-197697, a P-selectin Antagonist, Reduces Atherosclerosis in Apolipoprotein E Deficient Mice
Bedoya G	-	The First Homozygous Family for Factor II G20210A Mutation in Latin America
	-	Thrombophilia in a Healthy Population from Northwest Colombia
Beeton L	-	Genetic Variation within the Interleukin 6 Promoter Determines Interleukin 6 Expression Levels in Atherosclerosis
Begley GS	-	Precursors of Novel Gla-Containing Conotoxins Contain a Carboxy-Terminal Recognition Site that Directs g-Carboxylation by g-Glutamyl Carboxylase
Begtrup K	-	No Influence of Antiplatelet Therapy on the Outcome of Acute Intracerebral Haemorrhage Treated with Recombinant Activated Factor VII
	-	Effects of Recombinant Activated Factor VII on Perilesional Oedema in Patients with Acute Intracerebral Haemorrhage
Béguin S	-	The Relation Between in vitro Thrombin Generation and Signs of in vivo Thrombin Generation; Influence of Pro- and Anti-coagulant Plasma Factors
	-	The Effect of SC Injection of Heparins of Different Molecular Weight on Thrombin Generation – Consequences for the Question of Monitoring Heparin Treatment
	-	The Use of Calibrated Automated Thrombin Generation to Detect Alterations of the Clotting System Brought About by Hormone Administration in Pre- and Postmenopausal Women
	-	Rofecoxib (Vioxx) Increases Thrombin Generation in Platelet Rich Plasma
	-	The Thrombogram in Twins, Influence of Oral Contraceptive and Intercurrent Infection
Begum S	-	GPVI-Deficient Mice Lack Collagen Responses and are Protected Against Experimentally-Induced Pulmonary Thromboembolism
Behan MWH	-	Raised Blood Leukocyte Counts Markedly Alter Platelet Aggregation Extent induced by ADP and ATP via CD39
Beharry N	-	Extremely High Levels of Thrombospondin-1 in a Patient Afflicted with Rheumatoid Arthritis are Correlated with Activation of the Coagulation and Fibrinolytic Systems
Behrmann M	-	Epitope Mapping of the Factor VIII-specific T Cell Response in E-17 Knockout Mice Using Peptide Pool Arrays
	-	Both, COP I and COP II Coatomers Are Involved in the Anterograde ER to Golgi Transport of B-domain Deleted FVIII
Beijnen JH	-	Comparison of Protein Profile Analysis in Patients with and without a History of Venous Thromboembolism: A Pilot Study
Bein G	-	A Short Tandem Repeat Polymorphism Leads to Differential Expression of the Neonatal Fc Receptor
Belik J	-	Effect of Mechanical Ventilation on the Hemostatic State of the Newborn
Bellatorre AG	-	Homocysteine Plasma Levels and MTHFR Genotype in Patients with Retinal Vein Occlusion
Bellein V	-	Premature Atherosclerosis in HIV Positive Patients and Cumulated Time of Exposure to Antiretroviral Therapy (SHIVA Study)
Belli S	-	Relation Between Plasmatic Levels of Plasminogen Activator Inhibitor-1 (PAI-1) and Body and Liver Fat Content
Bellia M	-	Plasminogen Activator Inhibitor-1 -675 4G/5G and a -844 G Polymorphisms and Outcome of Patients with Sepsis
	-	References Values of roTEM Instrument
Bello T	-	Clinical Course and Management of 7 Patients with Congenital Factor XIII Deficiency. Experience of a Single Institution
Bellucci S	-	Acquired von Willebrand Syndrome Due to an Antibody Against von Willebrand Factor Associated to a Strong Platelet Thromboagglutinin Simulating a Type 2B von Willebrand Disease
Bellucci S	-	Molecular Basis of MYH9-Related Disorders in a Series of Ten Families
Bellucci S	-	Increased Platelet CD36 Antigen: A Useful Marker of Myeloproliferative Disorders. Parallel Evolution to That of BCR-abelson Transcript in Chronic Myeloid Leukaemia
Bellucci S	-	Prolonged Extracorporeal Life Support (ECLS) in Patients with Severe Membrane Stabilizing Agent (MSA) Poisonings: Hemostatic Management Requires only Minimal Doses of Heparin
	-	Usefulness of Platelet VASP Quantification to Monitor Antiplatelet Treatment by Thienopyridines
Beltran J	-	A New Fully Automated Functional Assay for TAFI Determination – STA® Stachrom® TAFI
Belvedere M	-	Pilot Dose Finding and Pharmacokinetic Study of Bivalirudin in Infants with Thrombosis
Belvini D	-	Gene Mutation and ITT Response in the Italian Cohort of Patients with Haemophilia A
Ben Lassoued MA	-	Antiphospholipid Syndrome and Risk of Myocardial Infarction in Young: A Preliminary Study
Ben Romdhane N	-	Antiphospholipid Syndrome and Risk of Myocardial Infarction in Young: A Preliminary Study
Benavente-García O	-	Antagonism of TxA2 Receptor Plays a Major Role in the Inhibitory Effect of Flavonoids in Platelet Function
Bendas G	-	Carbohydrate-Based P-Selectin Antagonists: In vitro- and In Vivo Investigations of Structure-Activity Relationships
Bender HG	-	Premature Onset of Fetal Loss Is Associated with the Polymorphism of Platelet Membrane Integrin a2b1 (a2807TT)
	-	The G20210A Prothrombin Gene Mutation and the Plasminogen Activator Inhibitor (PAI) 5G/5G Genotype Increase the Risk of Premature Onset of Severe Preeclampsia
	-	The IVS1-401 T-Allele of the Estrogen Receptor (ER)-a is an Independent Predictor of Late Fetal Loss
	-	Elevated Prothrombin Fragment F1 + 2 Levels during Pregnancy in Women with Previous Venous Thromboembolism
Bender T	-	Platelet Shape Change Stimulated by Low Concentration TP Receptor Agonist Is Independent of p38 MAP Kinase Pathway Activation But Requires Myosin Activation
Bendezú K	-	Relation Between Plasmatic Levels of Plasminogen Activator Inhibitor-1 (PAI-1) and Body and Liver Fat Content
Benegas M	-	Clinical Audit of Thromboembolism Prophylaxis 3 years after the 6th ACCP Report in a Tertiary Care Hospital in Córdoba, Argentina
Beneke H	-	Pregnancy of a Libanese Woman with Homozygous Protein C deficiency
Benfield C	-	The Application of New Diagnostic Guidelines in Type 1 von Willebrand Disease to Patients Previously Diagnosed Under the UK 1995 Guidelines. A Single Centre Paediatric Experience
Benhadda B	-	Haemophilia B in Female
Benisvy D	-	Low Molecular Weight Fucoidan Potentiates the Growth Factor-Induced Tube Formation By Endothelial Progenitor Cells
Bénit L	-	HZF as a Candidate Gene for Gray Platelet Syndrome (GPS)
	-	Lentivirus Destruction and DC-SIGN Expression by Platelets and Megakaryocytes
Benjamin RJ	-	Therapeutic Plasma Exchange (TPE) for Thrombotic Thrombocytopenic Purpura (TTP) Using Plasma Prepared With Photochemical Treatment: Clinical Responses, vWF CP Levels and vWF-CP Inhibitor Levels
Bennaghmouch A	-	Down-regulation of Tissue Factor Surface Expression by Annexin A5: a New Anticoagulant Mechanism
	-	Intracellular PAR Antagonists Have Anticoagulant and Antithrombotic Properties
Bennaghmouch A	-	Real-Time in Vivo Imaging of the Kinetics of Macrovascular Thrombus Formation
Bennett M	-	Tissue Factor Pathway Inhibitor (TFPI) during Cardiopulmonary Bypass (CPB) in Children
	-	Monitoring Haemostasis in Cardiopulmonary Bypass in Children – Measures of Heparin Activity
Bennett CE	-	CCAAT Enhancer Binding Proteins: Co-Regulators of Haemostasis and the Metabolic Syndrome?
Bennett M	-	Platelet Changes during Cardiopulmonary Bypass in Children
Bennett JS	-	Kinetics of Fibrinogen Binding to aIIbb3 Binding Studied at the Single Molecule Level Using Optical Tweezers
Bennett JS	-	Heteromeric and Homomeric Transmembrane Domain Associations Regulate aIIbb3 Function
Bennett MR	-	Apoptotic Mechanisms Underlying High-Risk Plaque
Ben-Shlomo Y	-	Which Haemostatic Variables Add to the Prediction of Cardiovascular Events by Conventional Risk Factors? The Caerphilly Study
Benson E	-	Factor V Inhibitor Acquired after Exposure to High-Purity Topical Bovine Thrombin during Orthopedic Surgery
Benson J	-	The Relationship Between Genetic Variants in the Endothelial Protein C Receptor and Venous Thromboembolism
Beránek M	-	The Comparison of Thrombophilic Potential of F V Leiden and F II20210A in Heterozygous Form in Individuals from the East Bohemian Region
Berber E	-	A Pilot Study of a DNA Microarray-Based Approach for the Screening of Mutations in Hemophilia A
Berber E	-	A Pilot Study of a DNA Microarray-Based Approach for the Screening of Mutations in Hemophilia A
Berckmans RJ	-	Synovial Microparticles in Arthritic Patients Support Coagulation and Inflammation
Bercovich D	-	Endothelial Protein C Receptor (EPCR) Gene Polymorphisms and sEPCR Levels in Women with Recurrent Pregnancy Loss
Bereczky Z	-	Three Novel Heterozygous Mutations in a Patient with Type II Glanzmann Thrombasthenia
Bereczky Z	-	Three Novel Missense Mutations and Their Functional Consequences in Two Severe Inherited Factor X Deficiencies
Bereczky Z	-	Factor XIII Levels and Factor XIII a Subunit Val34Leu Polymorphism in Patients with Coronary Sclerosis and Myocardial Infarction
Béres BJ	-	Statins Do Not Interfere with the Antiplatelet Effect of Loading Dose Clopidogrel in Patients with Ischemic Heart Disease
Berger F	-	Complete Thrombolysis of Bilateral Pulmonary Embolism by Two-Sided Catheter-Directed Low-Dose Infusion of Tissue Plasminogen Activator
Berger K	-	Quality of Life in Patients with Haemophilia – An European Comparison Study (ESCHQoL)
Berger M	-	Venous Thromboembolism: Involvement of ADAMDEC1 Polymorphisms in Familially High Factor VIII Levels
Berger U	-	Autologous Bone and Marrow Grafted within a Clot of Platelet Rich Plasma Construct Normal Viable Bone
Bergman GE	-	Cross-over Comparative Study of Tolerability, Pharmacokinetics and Efficacy of Two Forms of Porcine Factor VIII in the Canine Model of Hemophilia A
Bergmann F	-	Anti-Prothrombin Antibodies in Women with Vascular Pregnancy Complications and in Patients with Thrombosis and Suspected Antiphospholipid Syndrome (APS)
Bergmann JF	-	Observed Rates of Clinically Apparent Venous Thromboembolism and Death Due to Pulmonary Embolism Among Unselected Hospitalized Acutely Ill Medical Patients Compared to Rates Predicted from Clinical Trials
	-	Venous Thromboembolism Prophylaxis in Acutely Ill Medical Patients in Intensive Care Units
	-	Interaction between Paracetamol and Warfarin: A Double-Blind Placebo-Controlled Randomised Study
	-	Physician Practices for Providing Venous Thromboembolism Prophylaxis to Hospitalized Acutely Ill Medical Patients:  Findings from the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE)
	-	The Predictive Value of D-Dimers on the Occurrence of Thromboembolic Events and Death: A Prospective Multicentric Study
Bergmeier W	-	CalDAG-GEFI and Protein Kinase C (PKC) Represent Alternative Pathways Leading to Activation of Integrin aIIbb3 in Platelets
Bergmeier W	-	Inhibition of Platelet Glycoprotein Ib (GP Ib) by a Monoclonal Antibody Prevents Platelet Dependent Thrombosis in Mice
Bergmeister H	-	Inhibition of the Transcription Factor EGR-1 Significantly Reduces Neointima Formation in a Rabbit Iliac Artery Angioplasty Model
Bergqvist D	-	Does the PE Risk in Abdominal Cancer Reflect Location, Spread or Tumour Type? Observations from a Population-Based Autopsy Study
	-	The Risk of Proximal DVT and Pulmonary Embolism (PE) in Patients with Objectively Verified Arterial Thrombosis. A Population-Based Autopsy Study
	-	Risk Factors for VTE In Patients Undergoing Abdominal Surgery: Lessons from the PEGASUS Trial
	-	Prevalence and Risk of Pulmonary Embolism in Patients with Intracardiac Thrombosis. A Population-Based Study
Beris A	-	Is Screening for Thrombophilia Mutations Necessary Prior to Free Functional Muscle Transfer?
Berk BC	-	Atheroprotective Mechanisms of Steady Laminar Blood Flow
Berland Y	-	Endothelial Microparticle Elevation in Uremia: A New Aspect of Endothelial Dysfunction Related to Uremic Toxins
Bermejo E	-	Comparative Effects of Nitroxil (HNO) and NO on Platelet Function and Tyrosine Phosphorilation Pattern of Activated Human Platelets
Bermúdez MM	-	Acquired Antithrombin Deficiency in Acute Lymphoblastic Leukaemia (ALL) Induced by L-Asparaginase (ASNase): A Conformational Mechanism Modulated by Dexamethasone
Bernard A	-	Exposure to Diesel Nanoparticles Does Not Induce Blood Hypercoagulability in an at-Risk Population
Bernard M	-	Evolution of Antithrombin (AT) and Fibrinogen (Fg) Levels during Induction Chemotherapy with L-asparaginase (Asp) in Adult Patients with Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL). Clinical Outcomes and Use of Coagulation Supportive Treatments: The CAPELAL Study
Bernardi F	-	Fluorescence-Based Study of Nonsense Mutation Suppression in Coagulation Factor VII Deficiency
	-	Thrombin Generation and Activated Protein C Resistance in Factor V Leiden Pseudo-homozygous Patients
Bernardi E	-	Different Thromboprophylaxis Approaches in Patients Undergoing Knee Arthroscopy (KANT Study): A Prospective Randomized Study
Bernardi F	-	Factor VIII:c Levels in Subjects with the Factor V R2Ppolymorphism
Bernardi F	-	Intragenic and Extragenic Components Modulating Coagulation Factor VIII Levels and the Risk of Venous Thrombosis
Bernardi M	-	Factor VIII and von Willebrand Factor Changes after Desmopressin and During Pregnancy in Type 2M von Willebrand Disease Vicenza: A Prospective Study Comparing Patients with Single (R1205H) and Double (R1205H-M740I) Defect
	-	Association of FVIII/Von Willebrand Factor Measurements and PFA-100® with Bleeding Score in Type 1 Von Willebrand Disease (VWD) Families. The MCMDM-1 Study
Bernardi F	-	CRM+ Factor V Deficiency Arg2080Cys: A Model to Investigate Altered C2 Domain-Membrane Interaction
	-	Natural Mutations in the 4th EGF-Like Domain of Protein S Alter GLA and SHBG Domain Interactions
Bernardi E	-	The Risk of Recurrent Venous Thromboembolism after Stopping Anticoagulation in Patients with Acute Deep Vein Thrombosis or Pulmonary Embolism. A Multicentre Prospective Cohort Study in 1626 Patients
Bernardi F	-	Polymorphisms in the Hemostatic Pathway Genes and the Risk of Myocardial infarction in Patients with Advanced Coronary Artery Disease. Results from the Verona Heart Project
Bernardo F	-	High Rate of Non Responders to Aspirin and/or Clopidogrel Treatment in the First Days Following Percutaneous Coronary Interventions: An Ex Vivo Study
Bernasconi S	-	Different Reactivity of Factor VIII Inhibitor in Congenital and Acquired Haemophilia A
	-	Immunotolerance Induction (ITI) with High Purity FVIII/VWF Concentrates in Inhibitors Patients with a High Risk of a Poor Response to ITI: A Prospective Surveillance
Bernasconi A	-	Hyperhomocysteinemia, Anticardiolipin Antibodies, and Risk for Vascular Access Thrombosis in Hemodialysis Patients
Berndt M	-	Regulated Shedding of Platelet Receptors Glycoprotein VI and Glycoprotein Ib
	-	Glycoprotein (GP) VI Is Associated with GP-Ib-IX-V on the Membrane of Resting and Activated Platelets
	-	Interaction of Calmodulin with the Platelet ADP Receptor P2Y1
Berndt MC	-	Signaling Mediated by Glycoprotein Ib-IX-V/VWF Interaction Mainly Takes Place in GEMs In Human Platelets
	-	The Platelet Actin Cytoskeleton Dynamically Reorganizes into Podosomes Upon Cell Adhesion. Identification of a Novel Actin-rich Adhesive Structure in Human Platelets
Berndt M	-	Regulation of Platelet Receptors
	-	Platelet GPIb-IX-V-Dependent Signaling
	-	A Critical Role for 14-3-3 Protein in Regulating the VWF Binding Function of the Platelet Glycoprotein Ib-IX
Berneman Z	-	Safe Exclusion of Deep Vein Thrombosis (DVT) by a Normal Rapid ELISA D-Dimeer (<500 Ng/Ml) and by the Combination of a Negative Compression Ultrasonography and a D-Dimer of <1000 Ng/Ml in 1330 Consecutive Outpatients with Suspected DVT in the Primary Care Setting
	-	Characterisation and Classification of Von Willebrand Diseases
Bernhard N	-	Aspirin Induces Receptor Shedding in Platelets by TNFa–Converting Enzyme (TACE)
Bernier M	-	Use of D-Dimer (DD) in The Management of Suspected Deep Venous Thrombosis and Pulmonary Embolism in the Emergency Room: Prospective Observations Over 1 year
Berntorp E	-	Clinical Efficacy and Safety Evaluation of ADVATE Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method (rAHF-PFM) During Surgical and Invasive Procedures
	-	Risk Factors for Venous Thrombosis in Swedish Children and Adolescents
	-	Treatment of Chronic Hepatitis C Infection in Patients with Hemophilia or Von Willebrand Disease with a Combination of Pegylated Interferon and Ribavirin
Berntorp E	-	Unresolved Challenges with Prophylaxis
	-	Long-term Prophylaxis in VWD. The Swedish Experience
Berrou J	-	Thrombin Induced Upregulation of Plasminogen Activator Inhibitor 1 (PAI-1) is Mediated by a Pathway Including S100 A9 Ca++ Binding Protein
Berruyer M	-	Identification and Characterization of 10 Novel Mutations Causing Factor XI Deficiency
	-	Fibrinogen Variants of the Gamma Chain Coiled-Coil Portion Detected by Reverse Phase HPLC in Patients with Venous Thrombosis
Berry LR	-	Biodistribution of a Covalent Antithrombin-Heparin Complex
	-	Inhibition of Coagulation Cascade Enzymes by a Covalent Antithrombin-Heparin Complex
	-	Comparison of Continuous and Subsampling Determination of Thrombin Generation in the Presence of Anticoagulants
	-	Comparison of Continuous and Subsampling Methods for Analysis of Thrombin Generation
	-	Reaction of Clot-Bound Thrombin with a Covalent Antithrombin-Heparin Complex Results in an Anticoagulant Surface
Berry LR	-	Effect of Mechanical Ventilation on the Hemostatic State of the Newborn
Berry LR	-	Analysis of Plasma Proteins Bound to Catheter Surfaces
Bertagnin A	-	Utility Of D-Dimer in the Diagnosis of Deep Venous Thrombosis in Hospitalized Patients at High Risk of Venous Thromboembolism
Bertelsen V	-	Lupus Anticoagulant (LA) is Significantly Associated with Inflammation Among Patients Suspected for Deep Vein Thrombosis (DVT)
	-	Alterations of the Tissue-Factor Induced Pathway of Coagulation during Acute Deep Vein Thrombosis (DVT): Significant Increase in Tissue-Factor Pathway Inhibitor (TFPI)
Bertina RM	-	Effects of Arginine Vasopressin 2 Receptor Polymorphisms on von Willebrand Factor and Factor VIII Levels and the Risk for Venous Thrombosis
	-	ABO Blood Group Genotypes and the Risk of Venous Thrombosis: Effect of Factor V Leiden
Bertina RM	-	Haplotypes of the Fibrinogen Genes, Plasma Fibrinogen Levels and the Risk of Deep Venous Thrombosis
Bertina RM	-	The Marburg I Polymorphism of Factor Seven-Activating Protease Is Not Associated with Venous Thrombosis
	-	The Effect of ABO Blood Group Genotypes on the Loading of von Willebrand Factor with A and B Antigens
	-	Effects of Arginine Vasopressin 2 Receptor Polymorphisms on von Willebrand Factor and Factor VIII Levels and the Risk for Venous Thrombosis
	-	Factor VIII Coagulant Activity and Antigen Levels Increase the Risk of Venous Thrombosis; Results of the MEGA Study
	-	Association of Coagulation Factor VIII Haplotypes with Factor VIII Activity and the Risk of Venous and Arterial Thrombosis
	-	Interleukin 1 Haplotypes and the Risk of Venous Thrombosis
	-	The Prothrombin G19911A Is a Functional Non-coding Polymorphism
	-	Influence of Polymorphisms in the Endothelial Protein C Receptor Gene on the Risk of Venous Thromboembolism in Carriers of the Factor V Leiden Mutation
	-	Protein CValencia: Symptomatic Type II Protein C Deficiency Associated with a Mutation in the Gla Domain (Glu16 to Lys)
Bertocco S	-	A Common Pathogenetic Link between Venous Thrombosis and Atherosclerosis: Increased Prevalence of Small, Dense LDL
Bertoglio S	-	Risk Factors for CVC-Associated Thrombosis in Cancer Patients: Analysis of the ETHIC Study
Bertoldi A	-	Prevalence of Thrombophilic Abnormalities in Patients with Deep Vein Thrombosis or Pulmonary Embolism
	-	Duration of Anticoagulant Treatment and Recurrence of Venous Thromboembolism in Patients with and without Thrombophilia
Bertomoro A	-	FV Leiden Mitigates Bleeding Tendency in Recessive Type 1 von Willebrand Disease
	-	How von Willebrand Factor Survival Contributes to Determining von Willebrand Disease Phenotype
Bertoncello K	-	Association of FVIII/Von Willebrand Factor Measurements and PFA-100® with Bleeding Score in Type 1 Von Willebrand Disease (VWD) Families. The MCMDM-1 Study
	-	Factor VIII and von Willebrand Factor Changes after Desmopressin and During Pregnancy in Type 2M von Willebrand Disease Vicenza: A Prospective Study Comparing Patients with Single (R1205H) and Double (R1205H-M740I) Defect
Bertoni A	-	Study of the Role of Membrane Lipid Rafts in Estrogen Signaling in Human Platelets
Bertrand MA	-	WILFACTIN: Efficacy and Safety Evaluation of WILFACTIN (a Triple Secured Von Willebrand Factor Product with a Low Factor VIII Content) in Women with Severe Von Willebrand Disease during Gynaecological/Obstetrical Events
Bertrand N	-	Interaction between Paracetamol and Warfarin: A Double-Blind Placebo-Controlled Randomised Study
Bethel M	-	A Comparison of Calibration Curves Using Unfractionated Heparin, Enoxaparin, Dalteparin, and Fondaparinux in a Chromogenic Anti-FXa Assay
	-	Intrinsic Factor Responsiveness of an aPTT Reagent Is Significantly Influenced by the Type of Factor Deficient Plasma Used
Bettis B	-	Induction of Tolerance to b2Glycoprotein I in Mice
Betts L	-	Crystal Structure of CIB1, an Endogenous Inhibitor of Platelet Integrin aIIbb3 Activation: Delineation of a New Family of Calcium-Binding Proteins
Betz C	-	The Relation of Laboratory and Clinical Features to the Response to Plasma Exchange Therapy in the Treatment of Acquired Thrombotic Thrombocytopenic Purpura (TTP)
Beurrier P	-	Immune Tolerance Induction with Highly Purified Plasma-Derived Factor VIII Containing Von Willebrand Factor in Hemophilia a Patients with High-Responding Inhibitors
Bevan DH	-	Use of Recombinant Activated Factor VII (Novoseven) as Haemostatic Cover for Surgery in Congenital Factor VII Deficiency
Beveridge M	-	Effect of Sample Collection Conditions on Interleukin-18, Serum Amyloid – A and Monocyte Chemo-Attractant Protein-1 ELISA Measurement in Human Serum
Bevers E	-	Intracellular PAR Antagonists Have Anticoagulant and Antithrombotic Properties
	-	Phosphatidylserine Exposure During Platelet Stimulation Is Caused by Activation of Scramblase and Inactivation of Aminophospholipid Translocase in a Distinct Platelet Fraction
Beyzadeoglu H	-	The Prevalence of Von Willebrand's Disease in Trakya Region of Turkey
Bezat-Bouchahda C	-	Secretion of Functional Plasma Coagulation Proteins in Long-term Primary Cultures of Human Hepatocytes
Bezemer M	-	Down-regulation of Low-Density Lipoprotein-induced Platelet Signaling
	-	Platelet Activation by Oxidized Low-Density Lipoprotein Is Mediated by CD36 and Scavenger Receptor-A
Bezemer ID	-	MTHFR C677T and the Risk Of Venous Thrombosis – Interaction with Factor V Leiden and Prothrombin G20210A Mutations
Bezerra-Neto JE	-	Treatment of Extensive Venous Malformation-Associated Localized Intravascular Coagulation with Interferon-Alpha: Case Report
Bhagwanbali V	-	Pathogenesis of Increased VWF Levels and the Association with the Risk of Ischemic Stroke: Proteolysis, Inflammation or Genetic Variation?
Bhakta V	-	Fusion of the N-terminal Acidic Domain of Heparin Cofactor II to a1-PI M358R Increases the Rate of Thrombin Inhibition
Bhatt DL	-	Use of Plateletworks™ vs. Arachidonic Acid Aggregation to Detect Aspirin Effect in Healthy Volunteers
Bhimavarapu A	-	Antibody to C1 Domain of Factor VIII Alters Interaction of Factor Xase Complex with Factor X
Böhm M	-	What Causes Patients with Acquired Thrombotic Thrombocytopenic Purpura to Relapse?
	-	The Relation of Laboratory and Clinical Features to the Response to Plasma Exchange Therapy in the Treatment of Acquired Thrombotic Thrombocytopenic Purpura (TTP)
Bhoopalam N	-	Circulating Inhibitor in an Elderly Female That Impairs the Action of Human But Not Rabbit Brain Thromboplastin
Bialonczyk C	-	Risk Factors for the Postthrombotic Syndrome (PTS)
	-	Tissue Factor Pathway Inhibitor and the Risk of Recurrent Venous Thromboembolism (VTE)
	-	Prediction of the Risk of Recurrent Venous Thromboembolism by the Activated Partial Thromboplastin Time
	-	A Positive Family History of Venous Thromboembolism Does Not Predict A High Risk of Recurrence
	-	C-Reactive Protein 3'UTR (+1444) C>T Polymorphism in Patients with Spontaneous Venous Thromboembolism
Bianchi M	-	Clinical Experience with Optional Vena Cava Filters: Results of a Prospective Observational Multicenter Study
Bianchini EP	-	Thrombin-Activatable Factor X Re-establishes an Intrinsic Amplification in Tenase-deficient Plasmas
Bianchini EP	-	Ratcheting Between Two Distinct Conformations of Substrate Drives the Sequential Cleavage of Prothrombin by Prothrombinase
Biasini-Rebaioli C	-	Antiphospholipid Antibodies in 42 Neonates Born to Mothers with the Antiphospholipid Syndrome and Included in the European Forum Register
Biasoli CD'IncàM	-	Inherited Bleeding Disorders: The Emilia-Romagna Region Register, 2004 Update
Bick RL	-	Biochemical and Pharmacological Equivalence of Generic Versions of Low Molecular Weight Heparins. A Comparative Study with Innovator Products
Bick R	-	Nitric Oxide Levels Are Elevated in Patients with Malignancy Associated Hypercoagulable State
	-	Differential Modulation of Thrombin Activatable Fibrinolytic Inhibitor by Unfractionated Heparin
Bickeböller H	-	Venous Thromboembolism: Involvement of ADAMDEC1 Polymorphisms in Familially High Factor VIII Levels
Bickel C	-	Haemostatic Factors and the Risk of Cardiovascular Death in Patients with Coronary Artery Disease: The AtheroGene Study
Bidligmaier C	-	Long-Term Safety and Efficacy Data on Neonatal Thromboembolism Treated with Dalteparin or Enoxaparin: A Comparison of Once Daily Versus Twice Daily Administration
Bidlingmaier C	-	Patient Privacy and Data Security in Web-Based Databases
	-	Risk of Recurrent Venous Thromboembolism in Children with Cerebral Venous Thrombosis – A Prospective Follow-Up Cohort Study
Bidot C	-	Antiphospholipid Antibodies and Platelet Activation as Thrombotic Risk Factors in Thrombocythemia Associated with Myeloproliferative Disorder
	-	Interstitial Pulmonary Lesions in Patients with Recurring Severe ITP
	-	ITP Developing in Spouses of Patients with Chronic ITP: ‘Spousal ITP’
Bieche I	-	The TM -1208/-1209delTT Gene Promoter Polymorphism and Circulating Monocyte Thrombomodulin (TM) Gene Expression in 100 Healthy Volunteers
Bièche I	-	Elevated Gas6 Plasma Levels in Patients with Severe Sepsis
Bienek C	-	A New Double Virus Inactivated 4-Factor Prothrombin Complex Concentrate (4F PCC)
Bierhaus A	-	Hyperglycemia Induces Loss of the Protective Endothelial Thrombomodulin Protein C System
Bierings R	-	Von Willebrand Factor-mediated Sorting of Endothelial Secretory Proteins
Bierings R	-	Protein Kinase A-dependent Clustering of Weibel-Palade Bodies in Endothelial Cells
Biesert L	-	Removal of PrPSc in the Manufacturing Process of OCTAPLAS and UNIPLAS
Biesert L	-	Characterisation of the Novel, High Purity, Double Virus Inactivated von Willebrand Factor and Factor VIII Concentrate Wilate
Biesert L	-	Viral Safety of a Novel von Willebrand Factor and Factor VIII Concentrate (Wilate®): Virus Inactivation Capacities of Optimised Solvent/Detergent and Terminal Dry-Heat Treatment
	-	Viral Safety of a Prothrombin Complex Concentrate (Octaplex®): Combination of Solvent/Detergent (SD) Treatment with Nanofiltration
Biesma DH	-	Fibrin Monomers in the Diagnosis of Deep Vein Thrombosis
Biesma D	-	Stable Plasma D-dimer Concentrations after Prolonged Freezing
	-	The Clinical Probability Score and D-dimers Are Not Recommended in Elderly Patients Suspected for Having Deep Vein Thrombosis
Bifarini B	-	Coagulation Screening for Otorhinolaryngoiatric Surgery: A Pharmacoeconomic Appraisal in the Setting of the Italian National Health System
Bigi P	-	eNOS Gene Affects Blood Viscosity and Red Cell Deformability: Role of eNOS T-786C, G894T and 4a/4b Polymorphisms
Biglioli P	-	Platelet Associated Tissue Factor Expression in Patients with Antiphospholipid Syndrome
Biguzzi E	-	Glucosylceramide Synthase, Glucosylceramide Plasma-Based Assay and Prothrombotic Conditions
	-	Electrostatic Properties of Naturally Occurring Protein C Mutants by Computational Analysis
	-	Low Protein Z Levels and Venous Thrombosis
Bihoreau N	-	Evaluation of a New Manufacturing Process for Therapeutic Fibrinogen
	-	A Comparison of Two Manufacturing Processes for an Antithrombin Concentrate
Bijlsma MF	-	Coagulation Factors VIIa and Xa Promote Apoptosis in Human Tumor Cells in Association with CREB Activation
Bijsterveld NR	-	Effects of Clopidogrel on the Rebound Hypercoagulable State in Acute Coronary Syndromes (ACS) Patients after Heparin Discontinuation
Bild A	-	Gene Expression Profiling in Antiphospholipid Syndrome Reveals Distinct Molecular Signatures with Diagnostic Value
Bilgrami SA	-	Medroxyprogesterone Acetate-associated Relapse of Thrombotic Thrombocytopenic Purpura
Bílková J	-	Changes of Coagulation after Single i.v. Bolus 0.75 mg Per kg of Low Molecular Weight Heparin Enoxaparin During PCI – A Pharmacokinetic Study
Billett HH	-	Anticoagulation for Patients with Inferior Vena Cava Filters
Billing Clason S	-	Prothrombotic Risk Assessment of Patients Receiving Ximelagatran for Secondary Prevention of Venous Thromboembolism
Binder BR	-	Antiapoptotic Activity of Vascular Endothelial Growth Factor (VEGF) Is also Mediated by VEGF Induced Pro-urokinase (Pro-uPA) Activation
	-	TECHNOZYM® ADAMTS 13 Assays for Analyzing the vWF Cleaving Protease ADAMTS 13
	-	Thrombin Induced Upregulation of Plasminogen Activator Inhibitor 1 (PAI-1) is Mediated by a Pathway Including S100 A9 Ca++ Binding Protein
	-	Podoplanin-Induced Platelet Aggregation is Responsible For Separation of Blood and Sprouting Lymphatic Vessels during Embryonic Development
	-	Applications of Thrombin Generation Assay in Characterizing FVIII Bypassing Agents
	-	Diagnosis of Acute Idiopathic Thrombotic Thrombocytopenic Purpura by Rapid Detection of ADAMTS 13 IgG Antibodies
	-	Inhibition of the Transcription Factor EGR-1 Significantly Reduces Neointima Formation in a Rabbit Iliac Artery Angioplasty Model
	-	Characterization and Thrombogenicity of Microparticles Derived from Endothelial Cells, Smooth Muscle Cells, and Monocytes as Measured By a Novel Thrombin Generation Assay (TECHNOTHROMBIN® TGA)
	-	TECHNOTHROMBIN® TGA a Novel Thrombin Generation Assay Suitable for the New Routine Coagulation Analyzer Ceveron® Alpha
Biner B	-	The Prevalence of Von Willebrand's Disease in Trakya Region of Turkey
	-	The Correlation among Tissue Factor Pathway, Endothelial Damage Parameters and Lipid Profile in Children with Type 1 Diabetes Mellitus
Binetti BM	-	APC Resistance Caused by Prothrombin G20210A Mutation Does Not Affect the Fibrinolytic Activity of Activated Protein C
Biondi ML	-	Glucosylceramide Synthase, Glucosylceramide Plasma-Based Assay and Prothrombotic Conditions
Biró É	-	Complement Activation on the Surface of Cell-Derived Microparticles in Rheumatoid Arthritis
Birch B	-	Does Human Semen Contain a Functional Haemostatic System? A Possible Role for Tissue Factor Pathway Inhibitor in Fertility through Semen Liquefaction
	-	Seminal Factor VIII and von Willebrand Factor: A Possible Role of the Conventional Clotting System in Human Semen?
	-	Quantitation of Thrombin Activatable Fibrinolysis Inhibitor (TAFI) in Human Semen
	-	Tissue Factor Synthesis and Expression by Human Proximal Tubular Cells: the Source of Increased Urinary Tissue Factor Secretion in Disease?
Bird ML	-	Circulating Inhibitor in an Elderly Female That Impairs the Action of Human But Not Rabbit Brain Thromboplastin
Birkenes B	-	17b-Estradiol Lowers Production of Tissue Factor Pathway Inhibitor (TFPI) in HUVEC Cells
Biró E´	-	P-selectin- and CD63-Exposing Platelet Microparticles Reflect Platelet Activation in Peripheral Arterial Disease and Myocardial Infarction
Biron-Andréani C	-	Influence of 10 Polymorphisms Located in Genes Coding for Factors Involved in Coagulation and Fibrinolysis on the Risk of Venous Thrombosis in Factor V Leiden Homozygotes: Study of 233 Subjects
Biron-Andreani C	-	Factor V Leiden Mutation and Pregnancy Associated Venous Thromboembolism: A Meta-Analysis
Biron-Andreani C	-	Secretion of Functional Plasma Coagulation Proteins in Long-term Primary Cultures of Human Hepatocytes
Biss TT	-	Recombinant Factor VIIa in the Management of Major Haemorrhage: Use of a Prognostic Scoring System Can Help to Predict Outcome
Bissery A	-	Elevated Gas6 Plasma Levels in Patients with Severe Sepsis
Biswas KK	-	Endocannabinoid Anandamide Induces High Mobility Group Box 1 (HMGB1) Protein Release in Monocytes and Macrophages
Biswas KK	-	Thrombomodulin Binds Lethal Cytokine HMGB1 and Neutralizes Its Pro-inflammatory Activity: Novel Cytoprotective Action of Thrombomodulin
Bitsch N	-	Real-Time in Vivo Imaging of the Kinetics of Macrovascular Thrombus Formation
Bittdorf B	-	Comparative Study of Fibrinolysis Test Systems with A Special Focus on Variable Sample Handling (Different Transport Modalities/Arterial and Venous Catheterization)
Björck M	-	The Risk of Proximal DVT and Pulmonary Embolism (PE) in Patients with Objectively Verified Arterial Thrombosis. A Population-Based Autopsy Study
Bjørkøy G	-	Intersubject Variability in Intracellular and Surface Tissue Factor Distribution in LPS-Stimulated Monocytes
Bjørnarå BT	-	Long-Term Occurrence of Venous Thromboembolism after Major Joint Surgery
Black L	-	Utility of aPTT in Monitoring Unfractionated Heparin in Children
Blackburn J	-	Barriers to Appropriate Anticoagulation with Warfarin in Orthopedic Surgery
Blacklock L	-	D-dimer Stability of Specimens Stored AT -20 and -70 DEGREES Celsius
Blackney M	-	Ecarin Clotting Time Profile of TGN 255, a Novel Synthetic Intravenous Direct Thrombin Inhibitor
Blackwell S	-	Successful Management of Pregnancy in a Patient with Type III Von Willebrand Disease and Platelet Storage Pool Disorder
Bladbjerg EM	-	Alterations of the Tissue-Factor Induced Pathway of Coagulation during Acute Deep Vein Thrombosis (DVT): Significant Increase in Tissue-Factor Pathway Inhibitor (TFPI)
Blagojevic J	-	The Contemporary Presence of Elevated Levels of Factor VIII and PAI-1 Is a Risk Factor for Recurrent Thromboembolism. A Retrospective Case–Control Study
Blagojevich J	-	Tissue Factor Pathway Inhibitor (TFPI) and Thrombin Activable Fibrinolysis Inhibitor (TAFI) in Juvenile Deep Vein Thrombosis
Blair P	-	Differential Translocation of Syk, Akt, and Endothelial Nitric Oxide Synthase (eNOS) in Stimulated Platelets
Blais N	-	Optimizing Thromboembolic and Stroke Prevention: Interim Analysis of a Randomized Controlled Trial of Pharmacist-Managed Oral Anticoagulotherapy (PHARMA Trial)
	-	Prospective Sensitivity Comparison of Three Different D-Dimer Assays for Venous Thromboembolic Disease Exclusion Using a Standardized Diagnostic Algorithm
Blais L	-	Optimizing Thromboembolic and Stroke Prevention: Interim Analysis of a Randomized Controlled Trial of Pharmacist-Managed Oral Anticoagulotherapy (PHARMA Trial)
Blais N	-	Use of D-Dimer (DD) in The Management of Suspected Deep Venous Thrombosis and Pulmonary Embolism in the Emergency Room: Prospective Observations Over 1 year
Blamey CJ	-	Crystal Structure of Calcium- and Integrin-Binding Protein 1: Insights to a Novel Mechanism of Action
Blamey CJ	-	Identification and Characterization of Novel Members of the Calcium and Integrin Binding Protein Family
Blanchette VS	-	In Vitro Stability of Dilutions of the Recombinant Factor VIII Kogenate FS for Continuous Infusion Use
	-	Detection of Platelet Dense Granule Deficiency in Pediatric Patients by Quantitative Electron Microscopy
Blanchette V	-	Time In-Situ as a Risk Factor for Central Venous Catheter Associated Thrombosis (CVC-Clot) in Severe Hemophiliacs (SH)
	-	Efficacy, Safety and Pharmacokinetic Properties of ADVATE rAHF-PFM in Previously Treated Patients (PTPs) Less Than 6 years of Age
Blanchette VS	-	A Comparison of the Canadian Hemophilia Outcomes – Kids Life Assessment Tool (CHO-KLAT) and the HaemoQoL
Blanchette V	-	Results from the Canadian Hemophilia Dose Escalation Prophylaxis Trial: An Update
Blanchette VS	-	The Canadian Hemophilia Outcomes-Kids Life Assessment Tool (CHO-KLAT): Results of the Reliability and Validation Study
Blanco AN	-	Behaviour of the Two-Step Coagulation Assay to Identify Antib2-glycoprotein I (ab2GPI)-Lupus Anticoagulant (LA) in Patients with Antiphospholipid Antibodies
Blanco A	-	Anti Factor VIII Inhibitor: A Single Institution Experience
Blanco AN	-	Evaluation of Fibrinolytic Activity and Major Hemorrhages in Probable Type 1 Von Willebrand Disease
Blangero J	-	Effect of F7 Gene Promoter Polymorphisms on Factor VII Antigenic Levels
	-	A Genome Search for Genetic Determinants That Influence Plasma Fibrinogen Levels
	-	A Quantitative Trait Locus on Chromosome 12q14.1 Influences Plasminogen Levels in the San Antonio Heart Family Study (SAFHS)
Blankenberg S	-	Haemostatic Factors and the Risk of Cardiovascular Death in Patients with Coronary Artery Disease: The AtheroGene Study
Blann AD	-	Circulating Endothelial Cells in Acute Ischaemic Stroke
	-	Analysis of Combination Anti-Angiogenesis Therapy on Markers of Coagulation, Platelet Activation and Angiogenesis in Patients with Advanced Cancer
Blann A	-	Influence of the Tissue Factor Pathway on Initiation of Warfarin Anticoagulant Therapy
Blann AD	-	Plasma Levels of Tissue Factor and Soluble E-Selectin in Sickle Cell Disease: Relationship to Genotype and to Inflammation
	-	Soluble CD40L in Peripheral Artery Disease: Relationship with Disease Severity, Platelet Markers and the Effects of Angioplasty
Blann A	-	Effect on the Tissue Factor Pathway of Cessation of Warfarin Anticoagulant Therapy
Blann AD	-	Angiopoietin-1 and Angiopoietin-2 in Diabetes Mellitus: Relationship to VEGF, Glycaemic Control, Endothelial Damage/Dysfunction and Atherosclerosis
	-	Increased Circulating Endothelial Cells in Acute Congestive Heart Failure: Comparison with von Willebrand Factor and Soluble E Selectin
Blasbery K	-	Screening for Aspirin Responsiveness after TIA and Stroke in the Oxford Vascular Study: Comparison of Two Point of Care Platelet Function Tests with Aggregometry
Blatný J	-	Project HemIS (Haemophilia – Information System): Multicentric Information System of Patients with Haemophilia
Blatny J	-	Bleeding Prophylaxis in Children with Haemophilia A/B Using Plasma-derived Concentrates Immunate/Immunine – Prospective Survey
	-	Treatment of Life Threatening Bleeding with rFVIIa in 2001–2004 in Czech Republic. Presentation of 126 Cases with the Help of ‘UniSeven’ Registry
Blauth G	-	High Inter-Device Variation of the PFA-100™ Platelet Function Analyzer
Bla[zcaron]ek B	-	Project HemIS (Haemophilia – Information System): Multicentric Information System of Patients with Haemophilia
Blazek B	-	Bleeding Prophylaxis in Children with Haemophilia A/B Using Plasma-derived Concentrates Immunate/Immunine – Prospective Survey
Bledzka-Krupska K	-	Functional Analyses of the Reconstituted AlphaIIbbeta3 and AlphaVbeta3 Minireceptors
Bledzka-Krupska K	-	Refolding Characteristics of Recombinant Beta3(109-352) Fragment and Formation of a Functionally Active A-Domain
Bleijlevens B	-	SELDI-TOF MS: A Potential High-Throughput Tool for High-Density Lipoprotein Analysis
Bliden KP	-	Over Estimation of Aspirin Resistance: 1 Out of 143 Patients Exhibiting True Aspirin Resistance
Bliden K	-	Hypercoagulability Measured By TEG Strongly Predicts Recurrent Ischemic Stents Post Coronary Stenting
Bliden KP	-	The Relation of Dosing to Clopidogrel Responsiveness and the Incidence of High Post-Treatment Platelet Aggregation in Patients Undergoing Coronary Stenting
Bliden K	-	Viral Respiratory Tract Infections Increase Platelet Reactivity and Activation – an Explanation for Higher Rates of MyocardialInfarction and Stroke during Viral Illness
Bliden KP	-	Clopidogrel Effect on Platelet Reactivity in Patients with Stent Thrombosis: Results of the CREST Study
	-	High Dose Clopidogrel and Eptifibatide: The Optimum Strategy to Prevent Myocardial Necrosis in Elective Stenting? Results from the CLEAR PLATELET Study
Bliden K	-	Thromboelastography Is a Useful Predictor of Stent Thrombosis
Blinc A	-	Methyl-Methacrylate Bone Cement Surface Does Not Promote Platelet Aggregation or Plasma Coagulation in vitro
Blinc A	-	Ultrasonic and Magnetic Resonance Characteristics of Pulmonary Emboli Ex Vivo
Büller H	-	Initial Outpatient Treatment of Venous Thromboembolism with Fondaparinux (Arixtra®): The MATISSE trials
Blobel C	-	Determination of the Integrin Binding Properties of the Disintegrin-Like Loops of ADAM Proteins
Block K	-	Homozygous Protein C Deficiency: Identification of a Mutation with Clinical and Laboratory Heterogeneity
Blocklet D	-	Accuracy of Pretest Probability Assessment of Pulmonary Embolism by Junior Physicians Using the Explicit Wells Clinical Model
Bloemendal HJ	-	The Interaction of Platelets-tumor Cell Complexes with Vitronectin
Blom HJ	-	Evidence for a Critical Role of the Modifying Subunit of Glutamatecysteine Ligase in Homocysteine Pathophysiology
Blom H	-	Homocysteine Lowering by B Vitamins and the Secondary Prevention of Deep-Vein Thrombosis and Pulmonary Embolism. A Randomised, Placebo-Controlled, Double Blind Trial
Blom HJ	-	A Genome-Wide Linkage Scan for Homocysteine Levels Identifies Three Regions of Interest
	-	Low Methionine Concentration as a Risk Factor for Recurrent Venous Thrombosis
Blom JW	-	Upper Extremity Venous Thrombosis; Risk estimations for Surgery, Plaster Cast, Unusual Activities and Exercise
Blom H	-	Low Plasma Levels of Vitamin B6 and Recurrent Venous Thrombosis: Risk Assessment and Effect of Combined Vitamin Supplementation in the VITRO-Trial
Blombäck M	-	Low Dose-beneficial Effects of Acetylsalicylic Acid (ASA) Modify Fibrinogen Clotting Property in a Purified System Leading to Increase of the Fibrin Gel Porosity
	-	Hemostatic and Inflammatory Disturbances are Present in Ischemic Stroke
BlombergTörnqvist AH	-	Exposure to Diesel Nanoparticles Does Not Induce Blood Hypercoagulability in an at-Risk Population
Blömer L	-	Monocyte Subsets in Early Atherosclerosis – Lessons Learnt at Home
Blomstrand C	-	Fibrinolytic Gene Polymorphism and Ischemic Stroke
	-	C-reactive Protein Polymorphisms and Ischemic Stroke
Blostein M	-	Thrombophilia Is Not a Risk Factor for Peripheral Intravenous Infusion-Associated Thrombophlebitis
Blouch MT	-	Clinical Impact of Screening for Factor V Leiden First Degree Relatives of Patients with an Acute Episode of VTE in Association with Factor V Leiden
	-	Risk of a First Episode of Venous Thromboembolism (VTE) in First Degree Relatives of Patients with an Acute Episode of VTE in Association with Factor V Leiden: An Analysis According to Age of Patients
	-	Risk of a First Episode of Venous Thromboembolism (VTE) in First Degree Relatives of Patients with an Acute Episode of VTE in Association with Factor V Leiden
Blumenfeld Z	-	ProC Global Assay in the Evaluation of Women at Risk for VTE While Using Hormonal Therapy
Blumenstein M	-	Cystic Fibrosis is a Significant Risk Factor for Recurrent Venous Thrombosis at a Pediatric Tertiary Care Hospital
	-	May-Thurner Syndrome (Ileofemoral Vein Thrombosis) in Adolescents with Additional Thrombophilic Risk Factors
Bobe R	-	A Novel Case of Familial Thrombocytopenia with Evidence for a Critical Role of Proteins Involved in Ca2+ Signaling in Megakaryocytopoiesis
Boberg P	-	Case Report on Successful Use of Activated Prothrombincomplex Concentrate FEIBA® in Orthopedic Surgery on Two Patients with Factor VIII Inhibitors
Bobik A	-	Injury-Inducible Yin Yang-1 Inhibits Vascular Smooth Muscle Cell Growth and Intimal Thickening by Repressing p21WAF1/Cip1 Transcription and Perturbing Cyclin D1-Cdk4-p21WAF1/Cip1 Assembly
Bobik A	-	Effects of G-CSF/SCF on Cardiac Function and Cellular Repair Processes after Acute Myocardial Infarction
Bobkova I	-	Endotheliumdependent Factors of Haemostasis and Fibrinolysis in Some Renal Diseases
Bobrovnik S	-	Ischemia/Reperfusion Induces the Binding of Circulated Immunoglobulins to Blood Vessels
Boccalon H	-	Long-Haul Flights Do Not Activate Haemostasis in Young Healthy Men
Boccuzzi SJ	-	The Relationship Between INR Time-In-Range and Risk of Stroke and Major Bleeds in Chronic Non-Valvular Atrial Fibrillation Warfarin Utilizers
Bochenek A	-	Prediction of the Excessive Perioperative Bleeding in Patients Undergoing Coronary Artery Bypass Grafting: Role of Aspirin and Platelet Glycoprotein IIIa Polymorphism
Bock SC	-	Disruption of a Hydrophobic Cluster Surrounding Tyearosine-131 in the Native Conformation of Antithrombin III Activates it for Factor Xa Inhibition and Increases Its Affinity for Heparin
	-	Cofactor Binding – Dependent Hydrogen Bond Formation between Antithrombin III Strand 3A Tyrosine-220 and Strand 5A Glutamic Acid 374 Is Necessary for Backwards Conformational Adjustments Leading to Fully Developed Ionic Interactions between the Pentasaccharide and ATIII, and for Stabilization of High Affinity Heparin Binding
Bock PE	-	Prothrombin Colocalizes to the Platelet Thrombus and Vessel Wall Interface after Laser Induced Thrombosis Injury
Boczkowska-Radziwon B	-	The Effect of Continuous-flow Automated Plateletpheresis on Fibrinolytic Activity of Donor's Plasma
Boczkowska-Radziwon B	-	Diving and Decompression Have Significant Effect on the Activation of Fibrinolysis
Boda Z	-	Severe Acquired Factor XIII Deficiency Caused by an Autoantibody against the B Subunit
	-	Acquired FXIII Deficiency in a Patient with Systemic Lupus Erythematodes: Clinical Presentation and Management
Boda Z	-	Severe Thrombotic Complications of Heparin-associated Thrombocytopenia and Thrombosis
Boda Z	-	Three Novel Heterozygous Mutations in a Patient with Type II Glanzmann Thrombasthenia
Boddi M	-	More Carotid Atherosclerosis in HCV Positive Italian Patients?
Bode C	-	A Unique Fusion Protein Combines Clot Targeting, Platelet Blockade and Direct Factor Xa Inhibition in One Molecule
	-	Polymorphisms Known to Increase the Risk of Atherothrombosis Do Not Affect the Risk of Thrombembolism as Determined in Patients with Atrial Fibrillation
Bode W	-	Cofactor-induced Zymogen Activation
Bode C	-	Superparamagnetic Iron Oxide Uptake as Imaged By Magnetic Resonance Is Mediated by the Integrin Receptor MAC-1 (CD11b/CD18) – Possible Implications on Imaging of Atherosclerotic Plaques
	-	Design of Small Molecular Weight Activation-specific GPIIb/IIIa Inhibitors Based on the CDR3 Region of a Phage Display-derived Single-chain Antibody
	-	Selenium Causes Decreased Rolling and Adhesion of Monocytes under Venous Flow Conditions Via Shedding of L-Selectin (CD62L)
	-	Targeting of the Direct FXa Inhibitor TAP via the Fusion of a Single-chain Antibody Directed Against a LIBS Epitope on GPIIb/IIIa Provides Effective Anticoagulation without Bleeding Time Prolongation
Boden G	-	Circulating Tissue Factor Activity Is Increased by Hyperglycemia and Hyperinsulinemia in Normal Human Subjects
	-	24 Hours of Physiologic Hyperglycemia/Hyperinsulinemia Causes Platelet Activation Which Can Be Prevented in Vitro by Wortmannin (W)
Bodenbender W	-	Efficient Reduction of Prions by the Manufacturing Process of Plasma-Derived Products
Bodin L	-	A Mutation in Vitamin K Epoxide Reductase Complex Subunit-1 (VKORC1) in a Patient with Vitamin K Antagonist Resistance
Bodnar R	-	A Critical Role for 14-3-3 Protein in Regulating the VWF Binding Function of the Platelet Glycoprotein Ib-IX
Bodó I	-	Modeling VWF Catabolism Predicts the Multimer Pattern and Subunit Degradation in VWD Vicenza, Type 1, Type 2A, and Healthy Controls after DDAVP Infusion
Bodzenta-Lukaszyk A	-	The -675 4G/5G Plasminogen Activator Inhibitor-1 Promoter Polymorphism in House Dust Mite Sensitive Allergic Asthma Patients
Boehlen F	-	The Activation of Mouse Fibroblasts by Antiphospholipid Antibodies Requires TLR2
	-	Effect of Statins on Clopidogrel Platelet Inhibition as Measured by ADP Induced Platelet Aggregation and RPFA-P2Y12 (Accumetrics) in Healthy Volunteers
Boehm M	-	Rituximab in the Treatment of FXIII Inhibitor Possibly Caused by Ciprofloxacin
Boehm B	-	Factor VIII Activity and Antigen, VWF and ABO-Genotype Are Not Associated with Coronary Heart Disease
Boehncke WH	-	Chemically Distinct Anticoagulants Exert Differential Effects on Experimental Melanoma Metastasis
	-	Carbohydrate-Based P-Selectin Antagonists: In vitro- and In Vivo Investigations of Structure-Activity Relationships
Boekholdt SM	-	Serum Levels of Soluble Tissue Factor and the Risk of Future Coronary Artery Disease; The EPIC-Norfolk Prospective Population Study
Boekhorst J	-	13 Novel Mutations in the Factor VIII Gene in the Nijmegen Hemophilia A Patient Population
	-	The Importance of the Low-Density Lipoprotein Receptor-Related Protein (LRP) and Megalin Receptor in the Clearance of Factor VIII in Humans
	-	Discrepancy between FVIII Activity Peak Levels and Thrombin and Plasmin Generation in Severe Hemophilia A Patients Treated with FVIII
Boer K	-	Microparticles From Preeclamptic Patients Do Not Affect Transcription of Inflammation-related Genes in Endothelial Cells
	-	Microparticle-associated P-selectin Is a Marker of Platelet Activation in Preeclampsia
Boeri E	-	Prophylaxis with Factor VIII Protects Children with Hemophilia a from Inhibitor Development
Boerop J	-	In Type 2 Diabetes, P-Selectin- But Not CD63 -Exposing Microparticles Are Elevated in the Postprandial State
Boertjes RC	-	An Antibody Fragment Against Factor VIII That inhibits Factor VIII assembly with von Willebrand Factor and LDL Receptor Family Members
	-	Clusters of Ligand-Binding Domains of Low-density Lipoprotein Receptor-related Protein Bind both Heavy and Light Chain of Activated Factor V and Inhibit Cofactor Function
	-	Functional Duplication of Ligand-Binding Domains within Low-Density Lipoprotein Receptor-Related Protein for Interaction with Alpha2-Macroglobulin, Factor IXa and Factor VIII
Boezeman J	-	The Nijmegen Haemostasis Assay to Study the Interplay between Coagulation and Fibrinolysis
Boffa MC	-	Antiphospholipid Antibodies in 42 Neonates Born to Mothers with the Antiphospholipid Syndrome and Included in the European Forum Register
Boffa MC	-	Perinatal or Fetal Thrombosis in Babies Allowing Detection of the Anti-phospholipid Syndrome in Mothers
Boffard KD	-	Recombinant Activated Factor VII (rFVIIa, Novoseven®) in Coagulopathic Trauma Patients Significantly Reduces Blood Product Usage: Post-Hoc Subgroup Results from an International, Multi-Centre, Randomised, Placebo-Controlled, Double-Blind, Prospective Clinical Trial
Bogdanov IG	-	Comparative Analysis of the APC Resistance in East Siberian Residences
Boggio L	-	Catastrophic Antiphospholipid Antibody Syndrome: Successful Treatment with Immunosuppresive Therapy and Plasmapheresis
Boggio L	-	FEIBA Use for Acquired Hemophilia
	-	Fondaparinux Use in Heparin-Induced Thrombocytopenia
Boggio L	-	Embolic Stroke in Factor XI Deficiency after Recombinant Factor VIIa Use
Bohec C	-	Soluble CD146 in Women with Unexplained Pregnancy Loss: A New Insight. A Paired Case–Control Study
Böhm M	-	Clinical Manifestations of Patients with Dysfibrinogenemia
	-	ADAMTS 13 Activity and VWF : Ag Levels in Patients with Ischemic Stroke
Bohn RL	-	Post-marketing Surveillance of Thrombotic Events Among Users of rFVIIa and FEIBA: How Costly Are These Adverse Events?
Böing A	-	Congenital Deficiency of Factor XIII Caused by Two Missense Mutations in a Dutch Family
	-	Microparticles From Preeclamptic Patients Do Not Affect Transcription of Inflammation-related Genes in Endothelial Cells
Boinot C	-	Antiphospholipid Antibodies in 42 Neonates Born to Mothers with the Antiphospholipid Syndrome and Included in the European Forum Register
	-	Influence of 10 Polymorphisms Located in Genes Coding for Factors Involved in Coagulation and Fibrinolysis on the Risk of Venous Thrombosis in Factor V Leiden Homozygotes: Study of 233 Subjects
	-	Molecular Basis of MYH9-Related Disorders in a Series of Ten Families
Boissonnat P	-	MIP-1b and VE-Cadherin Are Implicated in Acute Rejection in Human Heart Transplantation
Boisson-Vidal C	-	Low Molecular Weight Fucoidan Potentiates the Growth Factor-Induced Tube Formation By Endothelial Progenitor Cells
Bokarev I	-	Predictive Value of Thrombus Precursor Protein for Recurrent Venous Thromboembolism
Bokarev IN	-	Study of the Methylenetetrahydrofolate Reductase Gene Promoter in Patients With Heterozygous C677T MTHFR Gene Polymorphism and Hyperhomocysteinemia
Bokarev I	-	Hyperhomocysteinemia Relapsing after Vitaminous Treatment: Relationship Between C677T Methylenetetrahydrofolatereductase (MTHFR) Genotype and Basal Homocysteine Level
Boldrin M	-	Long-Term Treatment with High-Dose Recombinant Human Antithrombin does not Prevent Acute Humoral Rejection in Primate Recipients of Porcine Xenografts
Bolis PF	-	Incidence of Deep Vein Thrombosis Following Gynecologic Laparoscopy: A Prospective Cohort Study
Bolli P	-	ACE DD Genotype: A Predisposing Factor to Abdominal Aortic Aneurysm
	-	High Risk of Recurrence in Renal Transplant Recipients after a First Episode of Venous Thromboembolism
	-	Antiaggreganting Agents Do Not Influence the Sonoclot Profile
Bolosiu HD	-	Associated Vitamin K Deficiency in Gaucher Disease Patients
Bomgaars L	-	A Phase II/III Clinical Study for the Determination of the Efficacy and Safety of Protein C Concentrate in Subjects with Severe Congenital Protein C Deficiency – Interim Study Analysis
Bonacini N	-	Resistance to Activated Proteine C (aPCR) in Subjects ‘Negative’ for Factor V Leiden (FVL) and ‘Positive’ for Antiphospholipid Antibodies (APL)
Bonar R	-	Towards Harmonisation of D-dimer Assays
	-	How Useful is the Monitoring of (Low Molecular Weight) Heparin Therapy by Anti-Xa assay? The Laboratory Perspective
Bonardo B	-	The TNF Alpha Converting Enzyme (TACE/ADAM17) Is Expressed in the Atherosclerotic Lesion of ApoE-deficient Mice
Boncela J	-	Binding Sites for PAI-1 Are Exposed in Fibrin But Not in Fibrinogen
Boncela J	-	Adhesive Properties and Fibrinolytic Response of Endothelial Cells Containing PAI-1 in the Complex with Alpha 1-Acid Glycoprotein Accumulated on Their Surface
Boncheva M	-	Rotation Thrombelstography Monitoring during Liver Transplantation
Boncler M	-	Impaired ASA-Mediated Formation of Thromboxane in Cholesterol-Depleted Blood Platelets
Bonduel M	-	Platelet Aggregation and ATP Release Values in Children and Adults
	-	Low Molecular Weight Heparin (LMWH) Therapy in Neonates and Children with Venous Thromboembolism (VTE)
	-	Oral Anticoagulation in Children. Have We Made Any Progress?
Boneu B	-	Long-Haul Flights Do Not Activate Haemostasis in Young Healthy Men
Boneu B	-	Screening of Factor V Leiden (FVL) and Risk-Assessment of Venous Thrombosis in Non-FVL-Carriers: Comparison of Different Methods for Activated Protein C Resistance (APCR) Measurement
Bongers TN	-	Pathogenesis of Increased VWF Levels and the Association with the Risk of Ischemic Stroke: Proteolysis, Inflammation or Genetic Variation?
	-	Highly Elevated Levels of Von Willebrand Factor in Patients with Liver Cirrhosis Support Platelet Adhesion Despite Its Reduced Functional Capacity
Bonifacio G	-	Thrombophilia in Women with Unexplained Fetal Loss
Bonifacio G	-	Residual Vein Thrombosis Assessment Establishes the Optimal Duration of Oral Anticoagulants in Patients with Idiopathic or Provoked Deep Vein Thrombosis: a Randomized, Controlled Trial
	-	Successful Treatment of Acquired Haemophilia with FEIBA® and Retuximab®
	-	Thrombophilia in Young Adults with Ischemic Stroke Not Related to Cardiovascular Risk Factors
	-	Objective Assessment of Pulmonary Embolism Can Be Deferred without Risk
Bonnefoy A	-	Domain A1 in Unfolded von Willebrand Factor Can Recruit Flowing Platelets to Collagen Surfaces Independently of Domain A3
	-	Thrombospondin-1 Secures Thrombus Adherence in vivo by Protecting (Sub)Endothelial VWF from Leavage by ADAMTS13
Bonnefoy A	-	Strong Antithrombotic Effect of the Type III Collagen-Related Octapeptide (KOGEOGPK) in the Mouse
Bonner L	-	Ambulatory Therapy of Patients with Free-Floating Proximal Deep Vein Thrombosis Is Safe
Bonnet JL	-	Circulating Endothelial Cell Count as a Diagnostic Marker for Non-ST Elevation Acute Coronary Syndromes
Bonnet M	-	High Concentrations of Procoagulant Microparticles in Patients with Multiple Trauma
Bonnet JL	-	Low Platelet Response to Clopidogrel Increased the Risk of Recurrent Atherothrombotic Events in Patients with Non-ST Acute Coronary Syndrome after Coronary Stenting
Bono F	-	Fgf-Receptor Signalling is Involved in Differentiation and Recruitment of Bone Marrow Progenitor Cells into Endothelial Progenitor Cells
Bono F	-	VEGF-R2 and Neuropilin-1 Are Involved in VEGF-A-Induced Differenciation of Human Bone Marrow Progenitor Cells
Bono M	-	DG-Chrom AT: A New Commercial Antithrombin (AT) Assay (Anti-FXa)
Boomsma F	-	Brain Natriuretic Peptide in Hemodynamically Stable Acute Pulmonary Embolism
Boonman-de Winter LJM	-	Preanalytical Variables and Off-Site Blood Collection: Influences on the Results of the Prothrombin Time/International Normalized Ratio Test and Implications for Monitoring of Oral Anticoagulant Therapy
Booth NA	-	a2-Antiplasmin Interaction with Endothelial Cells Via Integrins
	-	Regulation of Model Thrombus Lysis by TAFIa, PAI-1 and a2-Antiplasmin
	-	A Model Thrombus System for Assessing Thrombolysis
Borawski J	-	Plasmatic and Urinary Tissue Factor (TF) And Its Inhibitor (TFPI) Do Not Reflect the Activity of Human Chronic Glomerulonephritis
	-	Prolonged Euglobulin Clot Lysis Time does not Always Indicate Impaired Fibrinolysis in Chronic Hemodialysis Patients
	-	Novel Determinants of Increased Plasma Tissue Factor Level in Maintenance Hemodialysis Patients
Borel-Derlon A	-	Pharmacokinetic Study of the Co-administration of a Von Willebrand Factor (VWF) Product Containing Low FVIII Level (WILFACTIN) with a Factor VIII Product
	-	WILFACTIN: Efficacy and Safety Evaluation of WILFACTIN (a Triple Secured Von Willebrand Factor Product with a Low Factor VIII Content) in Women with Severe Von Willebrand Disease during Gynaecological/Obstetrical Events
Borensztajn K	-	Signal Transduction by Tissue Factor – An Unusual Cytokine Receptor
Borensztajn KS	-	Coagulation Factors VIIa and Xa Promote Apoptosis in Human Tumor Cells in Association with CREB Activation
Borg JY	-	Influence of 10 Polymorphisms Located in Genes Coding for Factors Involved in Coagulation and Fibrinolysis on the Risk of Venous Thrombosis in Factor V Leiden Homozygotes: Study of 233 Subjects
	-	Pharmacokinetic Study of the Co-administration of a Von Willebrand Factor (VWF) Product Containing Low FVIII Level (WILFACTIN) with a Factor VIII Product
	-	Protein Z Polymorphisms and Cerebral Venous Thrombosis
	-	Protein Z Polymorphisms, Protein Z Plasma Concentration and Severe Pre Eclampsia
Borg JY	-	Heparin-PF4 Elisa Antibodies Detection Is Not Relevant to Diagnose HIT During Sepsis
Borg JY	-	Activated Protein C Resistance and Factor V Arg306Thr Mutation: A Case Report
Borgel D	-	Natural Mutations in the 4th EGF-Like Domain of Protein S Alter GLA and SHBG Domain Interactions
Borggrefe M	-	Platelet Contractile Force and Clot Elastic Modulus Measured by Hemodyne Apparatus in Intensive Care Unit Patients: Identification of Patients with High Bleeding Risk
	-	Drotregocin Alfa (Activated) Down-Regulates RANTES in Peripheral Blood Mononuclear Cells of Septic Patients In Vivo
	-	Predictive Value of ISTH DIC-Score and aPTT Waveform Analysis at Admission to the ICU
Bork K	-	Hereditary Angioedema with Normal C1 Esterase Inhibitor: Studies on Two Families with Affected Women and Men
Bork K	-	Treatment with Pasteurized C1 Inhibitor Concentrate in Abdominal Pain Attacks of Patients with Hereditary Angioedema
Borm G	-	Low Methionine Concentration as a Risk Factor for Recurrent Venous Thrombosis
Bornstain C	-	Elevated Gas6 Plasma Levels in Patients with Severe Sepsis
Borowiec J	-	Nitric Oxide Enhances Eosinophil and Basophil Degranulation without Affecting Contact and Complement Activation
Borrell M	-	The ABO Blood Group Genotype and Factor VIII Levels as Independent Risk Factors for Venous Thromboembolism
Borrelli G	-	Prevalence and Clinical Significance of IgG and IgM Anti-Protein S (aPS) and Anti-Annexin V (aAV): Retrospective and Prospective Analysis of the WAPS Study
	-	Clinical Significance o IgG and IgM Anti-Phospholipid (aPL), Anti-Beta2-Glycoprotein I (aBeta2GPI), and Anti-Prothrombin (aPT) Antibodies: Retrospective and Prospective Analysis of the WAPS Study
Borris LC	-	Measuring Fragment 1 + 2 in Spot Urine to Determine the Thrombotic Potential after Hip Arthroplasty
	-	Prevention of Venous Thromboembolism with an Oral, Direct Factor Xa Inhibitor – BAY 59-7939 – in Elective Hip Replacement: A Dose-Ranging Study
Borroni L	-	Automated VWF : RCo for VWD Diagnosis
Bortoletto E	-	Mutations in Homozygotes and Compound Heterozygotes with FXII Deficiency
	-	Non-Catheter Induced Venous Thrombosis in Haemophellia A E B Patients
Borup R	-	Uremia-specific Effect on the Arterial Media during Development of Uremic Atherosclerosis in apolipoprotein-E Deficient Mice
Børvik T	-	Serum Osteoprotegerin in Young Survivors of Myocardial Infarction
Bos G	-	Low Plasma Levels of Vitamin B6 and Recurrent Venous Thrombosis: Risk Assessment and Effect of Combined Vitamin Supplementation in the VITRO-Trial
Bos MHA	-	Clusters of Ligand-Binding Domains of Low-density Lipoprotein Receptor-related Protein Bind both Heavy and Light Chain of Activated Factor V and Inhibit Cofactor Function
Bos G	-	Homocysteine Lowering by B Vitamins and the Secondary Prevention of Deep-Vein Thrombosis and Pulmonary Embolism. A Randomised, Placebo-Controlled, Double Blind Trial
Bosari S	-	Endothelial Protein C Receptor Is Expressed by CD83+ Dendritic Cells in the Human Gut Mucosa and Is Down-Regulated by Bacterial Antigens on Monocyte-Derived Dendritic Cells
Bosma K	-	The Older Hemophilia Patient with Inhibitors: Issues and Challenges
Bosman L	-	The Effect of Platelet Count on the Thrombelastograph® (TEG) Parameters
Bosman RJ	-	The Diagnosis and the Estimated Incidence of Heparin-Induced Thrombocytopenia in the Critically Ill According to ISTH SSC Criteria
Bosman L	-	Red Bloodcell Concentrates Reduces Clot Strength Measured with the Thrombelastograph® (TEG)
Bosmans JM	-	Pretreatment with Aspirin and Loading Dose Clopidogrel Obviates the Need for Glycoprotein Iib/Iiia Antagonists During Elective Coronary Stenting
Bossi A	-	D-Dimer Measurement after Acute Ischemic Stroke Does Not Predict Long Term Outcome Events
Bossuyt PMM	-	Predictors of Recurrent Venous Thromboembolism. Balancing Benefits and Risks – A Decision Approach
Bossuyt P	-	C-reactive Protein in Combination with Clinical Decision Rule and D-Dimer to Safely Rule out Pulmonary Embolism
Bostock JA	-	Clustering of Adipokines and Haemostatic Factors: Evidence for Transcriptional Co-regulation
	-	CCAAT Enhancer Binding Proteins: Co-Regulators of Haemostasis and the Metabolic Syndrome?
Boström SL	-	Human Aortic Endothelial Cells Inhibit Thrombin Generation in vitro and Augment Inhibition by Melagatran
Bostwick J	-	Development, Characterization and Application of Immunoassays for Mouse, Rat and Rabbit D-Dimer Using the Monoclonal Antibody FK03 in Animal Models of Thrombosis
Botchkov V	-	Characterization and Thrombogenicity of Microparticles Derived from Endothelial Cells, Smooth Muscle Cells, and Monocytes as Measured By a Novel Thrombin Generation Assay (TECHNOTHROMBIN® TGA)
Botikov AG	-	Using of PCR and RHA Tests for Detection of Hepatitis C Virus Antigen
Bottaro F	-	Validation of a Clinical Score (CS) Plus D-Dimer (DDi) Combination As a Diagnostic Strategy to Exclude Pulmonary Embolism (PE)
Bottenus R	-	Investigation of Performance and Sample Interferences for a New Automated Protein S Functional Activity Assay (HemosIL ProS)
	-	Characterization and Performance of the HemosIL Silica Clotting Time (SCT) Test for Detection of Lupus Anticoagulants
Botvinko IV	-	Interrelation Haemostasis and Intestinal Microbiota under Influence of Emotional Tension on Wistar Rats
Bouhassira E	-	Recombinant ADAMTS13 Refractory to Suppression by TTP Inhibitors
Boukas AE	-	An Inquiry into Death Causes Based on Autopsy Findings
Boukour S	-	Lentivirus Destruction and DC-SIGN Expression by Platelets and Megakaryocytes
Boulanger A	-	Spurious Decrease of Inhibitor Levels in Plasma Containing rFVIIa
	-	Clinical and Laboratory Response to rFVIIa and APCC in a Rare Case of Severe Congenital Factor VII Deficiency with an Inhibitor
Boulyguine OY	-	Fibrin-Monomer Prepared Using Thrombin-Like Enzyme from Snake Venom Agkistrodon Halys as Stimulator of Plasminogen Activation By t-PA
Bouma B	-	Factor XII (fXII) Is Activated by Unfolded Proteins on the Surface of Negatively Charged Substances, Rather than by These Surfaces Themselves
Bouma BN	-	Role of Isoleucine Residues 182 and 183 in Thrombin-Activatable Fibrinolysis Inhibitor
Bouma B	-	Activation of the Fibrinolytic System by Amyloid Cross-b Structure Results In reply to: Cell Detachment AND Processing of Neuroendocrine Factors
	-	Binding of Amyloid to the Fibronectin Type I Domain of tPA And Factor XII Induces Activation of the Fibrinolytic System and the Contact System
	-	Glycation Induces Formation of Cross-b Structure and Activation of Tissue-Type Plasminogen Activator (tPA) and Factor XII
Bounameaux H	-	Clinical Usefulness of D-Dimer Depending on Clinical Probability and Cut-Off Value in Outpatients with Suspected Pulmonary Embolism
	-	Lentiviral Vector-Mediated A20 Gene Transfer to Generate Endothelial (Progenitor) Cells that are Resistant to Inflammatory Stimuli
Bounameaux H	-	Lessons from Clinical Trials – Appropriate Outcomes
Bounameaux H	-	Swiss Atherothrombosis Survey – A Field report on the Occurrence of Symptomatic and Asymptomatic Peripheral Arterial Disease
	-	Characterization of Human Endothelial Progenitor Cells Under Various Flow Conditions
	-	Derivation and Validation of a Simple Standardized Clinical Score to Predict Pulmonary Embolism in Emergency Patients: The Revised Geneva Score
	-	Differential Value of Risk Factors and Clinical Signs for the Diagnosis of Pulmonary Embolism in Suspected Patients According to Age
	-	Multi-detector Row Computed Tomography in Outpatients with Suspected Pulmonary Embolism
	-	Plasma Levels of Gas6 and its Soluble Receptors In Severe Sepsis: Diagnostic and Prognostic Implications
	-	Isolation, Characterization and Angiogenic Potential of Human Mesenchymal Stem Cell-Derived Endothelial-Like Progenitor Cells
Boutière-Albanèse B	-	Different Patterns of Release of the Soluble Form of the Endothelial Protein C Receptor in Critically Ill Patients
Bouton MC	-	Modulation of Protease Nexin-1 Activity by Polysaccharides
Boutou AK	-	An Inquiry into Death Causes Based on Autopsy Findings
Bouziane K	-	Analytical Performances of a New Screening Assay to Evaluated the Functionality of the Protein C Anticoagulant Pathway, and Effect of Pre-Analytical Variables on the Test Result
Bouzourene K	-	Characterization of Human Endothelial Progenitor Cells Under Various Flow Conditions
	-	Egr-1: A Key Mediator of Oscillatory Shear Stress Induction of Tissue Factor Promoter
Boval B	-	Increased Platelet CD36 Antigen: A Useful Marker of Myeloproliferative Disorders. Parallel Evolution to That of BCR-abelson Transcript in Chronic Myeloid Leukaemia
	-	Acquired von Willebrand Syndrome Due to an Antibody Against von Willebrand Factor Associated to a Strong Platelet Thromboagglutinin Simulating a Type 2B von Willebrand Disease
	-	Usefulness of Platelet VASP Quantification to Monitor Antiplatelet Treatment by Thienopyridines
	-	Prolonged Extracorporeal Life Support (ECLS) in Patients with Severe Membrane Stabilizing Agent (MSA) Poisonings: Hemostatic Management Requires only Minimal Doses of Heparin
Bovenschen N	-	Clearance of Plasminogen Activator Inhibitor-1 in Low-Density Lipoprotein Receptor-Related Protein Deficient Mice
	-	An Antibody Fragment Against Factor VIII That inhibits Factor VIII assembly with von Willebrand Factor and LDL Receptor Family Members
Bovill EG	-	Attitudes about Genetic Testing for Thrombophilia in a Large Family with Heritable Protein C Deficiency
	-	Linkage Analysis Reveals No Evidence for Loci Other than the Factor VII Gene Influencing Factor VII Levels
	-	Evidence for Loci Pleotropically Influencing Inter-Related Clotting Factors
Bowen D	-	Molecular Pathogenesis of Type 1 von Willebrand Disease (VWD) – A UK National Study
Bowen DJ	-	Amino Acid Polymorphisms in the a Domains of von Willebrand Factor: Frequencies in the South Wales Population of the UK and Effect on Proteolysis By ADAMTS13
Bowers S	-	Evaluation of the Anticoagulant Effect of Enoxaparin by Using Clot Based Point of Care Tests
Bowman K	-	Non-Viral Gene Delivery for Treatment of Haemophilia a in Mice: Assessment of Low Factor VIII Levels Using a Fluorogenic Thrombin Generation Test (FTGT)
Boyer J	-	Phase 1 Pharmacokinetic, Pharmacodynamic, and Safety Evaluation of a Novel Rapidly Reversible Intravenous Platelet P2Y12 ADP Receptor Antagonist, INS50589
Boylan B	-	Immunodepletion of GPVI from Human Platelets Circulating in NOD/SCID Mice: Development of a Novel Animal Model for Evaluating the Therapeutic Efficacy of Compounds that Affect Human Platelet Function and Survival
Boz[breve]ic[breve] M	-	New Direct Thrombin Inhibitors Build on Azaphenylalanine Scaffold – Antithrombotic Effect in Two Rat Venous Thrombosis Models
Bozic M	-	Methyl-Methacrylate Bone Cement Surface Does Not Promote Platelet Aggregation or Plasma Coagulation in vitro
Bozzao C	-	In-vitro Expression and Functional Characterization of Four Mutations Causing Factor XI Deficiency
Bozzini C	-	Factor VIII:c Levels in Subjects with the Factor V R2Ppolymorphism
	-	Polymorphisms in the Hemostatic Pathway Genes and the Risk of Myocardial infarction in Patients with Advanced Coronary Artery Disease. Results from the Verona Heart Project
Brabec P	-	Treatment of Life Threatening Bleeding with rFVIIa in 2001–2004 in Czech Republic. Presentation of 126 Cases with the Help of ‘UniSeven’ Registry
Brackmann HH	-	Comparison of B-Cell Epitope and Mutation Type in Haemophilia A Patients
Bradford HN	-	The Antithrombotic Activity of Kininogen is Mediated by Inhibitory Effects of Domain 3 on Thrombin-Induced Platelet Activation, In Vivo
	-	High Molecular Weight Kininogen (HK) Fragments Stimulate the Secretion of Interleukin 1b (IL-1b) through CD11b/CD18 (Mac-1) in Human Blood Mononuclear Cells
Bradley CS	-	A Comparison of the Canadian Hemophilia Outcomes – Kids Life Assessment Tool (CHO-KLAT) and the HaemoQoL
	-	The Canadian Hemophilia Outcomes-Kids Life Assessment Tool (CHO-KLAT): Results of the Reliability and Validation Study
Braeunlich CG	-	A Short Tandem Repeat Polymorphism Leads to Differential Expression of the Neonatal Fc Receptor
Braganza DM	-	Apoptotic Mechanisms Underlying High-Risk Plaque
Brancaccio V	-	Higher Warfarin Requirement in Anticoagulated Antiphospholipid Syndrome Patients to Acquire the Target INR
Brandão L	-	Antiphospholipid Antibody Syndrome (APS) Experience in the Hospital for Sick Children
Brandao LR	-	Homozygous Protein C Deficiency: Identification of a Mutation with Clinical and Laboratory Heterogeneity
Brandao L	-	Utility of aPTT in Monitoring Unfractionated Heparin in Children
Brandão LR	-	Exercise-Induced Deep Vein Thrombosis of the Upper Extremity in Children: Management and Outcome in a Small Series
Brandao L	-	Tissue Plasminogen Activator (TPA) Therapy Resulting in Epidural Haemorrhage Following Intrathecal Therapy in a Pediatric Patient with Stage IV Burkitt's Lymphoma
Brandjes D	-	Plasma Levels of PAI-1 and Risk of Death from Dengue: No Association with the 4G/5G Promoter Polymorphism
Brandjes DP	-	Comparison of Protein Profile Analysis in Patients with and without a History of Venous Thromboembolism: A Pilot Study
Brandjes DPM	-	Naturally Occurring Acute Viral Respiratory Tract Infections in Elderly Patient Results in Increased von Willebrand and Enhanced Fibrinolysis
	-	The Role of PAI-1 Deficiency and a Reduced Capacity to Generate Activated Protein C on Coagulation Activation and Fibrin Formation during Murine Influenza Pneumonia
Brandão LR	-	Clinical and Laboratory Features of Mild Bleeding Disorders (MBD) in Children
Brandslund I	-	Patient Outcome during Oral Anticoagulant Therapy Using an Electronic Decision Support System
Brandt J	-	Use of the D-Dimer for Exclusion of VTE: Difficulties Revealed through the Proficiency Testing Program of the College of American Pathologists (CAP)
Brandt JT	-	Superior Inhibition of Platelet Aggregation Following a Loading Dose of CS-747 (Prasugrel, LY640315) Versus Clopidogrel: Correlation with the Pharmacokinetics of Active Metabolite Generation
	-	Effect of Ketoconazole on the Pharmacokinetics and Pharmacodynamics of CS-747 (Prasugrel, LY640315) and Clopidogrel in Healthy Subjects
Brassard J	-	Optimizing Thromboembolic and Stroke Prevention: Interim Analysis of a Randomized Controlled Trial of Pharmacist-Managed Oral Anticoagulotherapy (PHARMA Trial)
Braun S	-	Multicenter Evaluation of a New ELISA for the Determination of Prothrombin Fragment F 1+2
Braun-Dullaeus R	-	The Factor VII Activating Protease (FSAP) Is an Inhibitor of Neointimal Lesion Formation. Comparison with the Marburg I SNP (G511E) of FSAP
Brauner R	-	Bleeding Prophylaxis in Children with Haemophilia A/B Using Plasma-derived Concentrates Immunate/Immunine – Prospective Survey
Brautigan PJ	-	Expression Profiling Reveals Functionally Important Genes and Coordinately Regulated Signalling Pathway Genes During in vitro Angiogenesis
Bredoux R	-	A Novel Case of Familial Thrombocytopenia with Evidence for a Critical Role of Proteins Involved in Ca2+ Signaling in Megakaryocytopoiesis
Breimo E	-	Interleukin-8 (IL-8) Generation in Whole Blood Is Related to Markers of Atherosclerosis
Breimo ES	-	Blood Borne Tissue Factor: Weak TF Activity In Monocytes and Microparticles But Lack of TF Activity in Collagen/Thrombin Activated Platelets
Breimo E	-	The Eskimo Diet: More Than Omega-3 Fatty Acids
Breindahl M	-	Measuring Fragment 1 + 2 in Spot Urine to Determine the Thrombotic Potential after Hip Arthroplasty
Breit SN	-	A Mechanism of Impaired Platelet Response to ADP Stimulation in the CLIC1 Knockout Mice
Breitner-Ruddock S	-	Proteomics as a Tool for Assessment of Therapeutics in Transfusion Medicine: Evaluation of Prothrombin Complex Concentrates
Breitwieser A	-	TECHNOZYM® ADAMTS 13 Assays for Analyzing the vWF Cleaving Protease ADAMTS 13
Breña J	-	Clinical Course and Management of 7 Patients with Congenital Factor XIII Deficiency. Experience of a Single Institution
Brenkel I	-	Screening for Thrombophilia in High Risk Situations: A Meta-Analysis and Cost-Effectiveness Analysis
Brennan MP	-	Multiple Mechanisms for S. Aureus and S. Epidermidis Platelet Activation
Brennan M	-	Fibronectin-Binding Protein (FnBP) Mediates Staphylococcus Aureus-Induced Platelet Aggregation
	-	Development of a Mouse Serum Protein Map for Proteomic Research
Brenner B	-	ProC Global Assay in the Evaluation of Women at Risk for VTE While Using Hormonal Therapy
	-	Effect of Heparanase on TF Expression and TFPI Release
	-	Endothelial Protein C Receptor (EPCR) Gene Polymorphisms and sEPCR Levels in Women with Recurrent Pregnancy Loss
Brenner B	-	Tissue Factor Is Expressed and Active on Cultured Human Trophoblast Cell Surface; Possible Regulation by Angiogenic Stimuli
Bresser P	-	Alternative Clinical Diagnoses with Spiral CT in Patients with Suspected Pulmonary Embolism
	-	Lung-Protective Mechanical Ventilation Attenuates Fibrin Generation in Healthy Lungs
Bressollette L	-	Supperiority of Intermittent Pneumatic Compression of the legs over Elastic Stockings to Prevent Venous Thrombosis in Patients with Acute Intra-Cerebral Hemorrhage: A Randomized Trial
	-	Age May Modify the Relationship Between Factor V Leiden Mutation: but not G20210A Prothrombin Gene Variation: and Idiopathic Venous Thromboembolism: An Hospital-Based Case-Control Study
	-	Premature Atherosclerosis in HIV Positive Patients and Cumulated Time of Exposure to Antiretroviral Therapy (SHIVA Study)
	-	Recurrent Venous Thrombo-Embolism in Cancer Patients: Data from a Hospital-Based Case-Control Study
Brett S	-	Recombinant VIIa in Uncontrolled Haemorrhage
Bretthauer N	-	In-vitro Reversal of Anticoagulant Effects of Specific Factor Xa and Thrombin Inhibitors
Breuss J	-	Podoplanin-Induced Platelet Aggregation is Responsible For Separation of Blood and Sprouting Lymphatic Vessels during Embryonic Development
Breuss JM	-	Inhibition of the Transcription Factor EGR-1 Significantly Reduces Neointima Formation in a Rabbit Iliac Artery Angioplasty Model
Brüggemann LW	-	Alternatively Spliced Soluble Tissue Factor in Mice
	-	Antithrombotics Inhibit Tumor Metastasis
	-	FVIII-Dependent Propagation Phase Is of Minor Importance During Septic Peritonitis
Brian B	-	Neonatal Gene Therapy with Lentiviral Vector in Murine Hemophilia a Results in Successful Immune Tolerance Induction to Canine Factor VIII
Bridey F	-	Pharmacokinetic Study of the Co-administration of a Von Willebrand Factor (VWF) Product Containing Low FVIII Level (WILFACTIN) with a Factor VIII Product
	-	Bilateral Ankle Prosthesis in a Severe Von Willebrand Disease Patient under Substitutive Wilfactin Treatment
	-	WILFACTIN: Efficacy and Safety Evaluation of WILFACTIN (a Triple Secured Von Willebrand Factor Product with a Low Factor VIII Content) in Women with Severe Von Willebrand Disease during Gynaecological/Obstetrical Events
Briegel J	-	Heparin Abrogates the Positive Effect of High-dose Antithrombin III in Severe Sepsis (KyberSept Study)
Brieger D	-	Bleeding Events with Lytics and Thienopyridines in Patients with ST-Segment Elevation Myocardial Infarction. The Global Registry of Acute Coronary Events
Brieger D	-	Early Use of Low-Molecular-Weight or Unfractionated Heparin in Patients with Non-ST-Segment Elevation Myocardial Infarction and Unstable Angina. The Global Registry of Acute Coronary Events
Brighton T	-	Evaluation of DiaMed Heparin/PF4 Testing for HIT
Brighton TA	-	Low-Dose Aspirin for Secondary Prophylaxis of Vein Thrombosis – A Prospectively Planned Meta-Analysis
Brigulla M	-	Proteomics as a Tool for Assessment of Therapeutics in Transfusion Medicine: Evaluation of Prothrombin Complex Concentrates
Brill A	-	Platelet Mediated Clot Formation in Whole Blood under Flow: A New Screening Method for Coagulation Disorders and for Drug Monitoring
Brill A	-	Platelet-Derived Microparticles Induce Angiogenesis and Stimulate Post-Ischemic Revascularization
Brill A	-	Dynamic Responsiveness to Aspirin in Patients Undergoing PCI
Brill G	-	Platelets Promote CD4+ Lymphocyte Adhesion to Extracellular Matrix and Fibronectin Under Flow: Role of Integrins, CD40 Ligand and P-Selectin Glycoprotein Ligand-1
Brill A	-	CRP Induces Platelet-Endothelial Adhesion Under Flow
Brini M	-	Different Intracytoplasmatic Pattern of BCL-2 Family Proteins in Lymphocytes from Subjects Positive for Antiphospholipid Antibodies (APL)
	-	Resistance to Activated Proteine C (aPCR) in Subjects ‘Negative’ for Factor V Leiden (FVL) and ‘Positive’ for Antiphospholipid Antibodies (APL)
Briones M	-	Clinical and Laboratory Features of Mild Bleeding Disorders (MBD) in Children
Brisset AC	-	Microparticles from Smooth Muscle Cells Induce Endothelial Dysfunction, a Phenomenon Prevented by Glycoprotein IIb/IIIa Antagonists
Brito D	-	Immunotolerance Induction (ITI) with High Purity FVIII/VWF Concentrates in Inhibitors Patients with a High Risk of a Poor Response to ITI: A Prospective Surveillance
Britt M	-	Gene Expression Profiling in Antiphospholipid Syndrome Reveals Distinct Molecular Signatures with Diagnostic Value
Brittenden J	-	The Effects of Surgery on Platelet and Endothelial Function in Patients with Peripheral Arterial Disease and Severe Limb Ischaemia
	-	Evaluation of Aspirin Resistance in Peripheral Arterial Disease
	-	The Effects of Isometric and Treadmill Exercise on Platelet and Endothelial Function in Patients with Intermittent Claudication
Bro S	-	Uremia-specific Effect on the Arterial Media during Development of Uremic Atherosclerosis in apolipoprotein-E Deficient Mice
Bröcker-Vriends AHJT	-	Hemorrhagic risk in Female Carriers of Hemophilia
Brockhaus W	-	A Baltic Origin of the Common ADAMTS13 Mutation 4143insA
Brodde MF	-	New Function for Protease Inhibitors – Alpha1 Antitrypsin and Antithrombin III Inhibit the Activation of Platelets by Alpha Defensins from Neutrophils
Brodde MF	-	Prothrombotic Tendency upon Inflammatory Conditions – Alpha Defensins (HNP-1/2/3) Are Strong Platelet Agonists
	-	Albumin Mildly Oxidized by the Myeloperoxidase Product Hypochlorous Acid Strongly Activates Platelets and Monocytes Via CD36
Broderick J	-	Effects of Recombinant Activated Factor VII on Perilesional Oedema in Patients with Acute Intracerebral Haemorrhage
	-	No Influence of Antiplatelet Therapy on the Outcome of Acute Intracerebral Haemorrhage Treated with Recombinant Activated Factor VII
Brodin E	-	Increased Formation of Platelet-derived Microparticles by Heparin
Brodin E	-	Effects of Heparins on the Anticoagulant Function of Endothelial Tissue Factor Pathway Inhibitor (TFPI)
Brodin E	-	Serum Osteoprotegerin in Young Survivors of Myocardial Infarction
Brodin E	-	Heparin Induces Release of Osteoprotegerin (OPG)
Brogi D	-	Prevalence of Inflammatory Gene Polymorphisms in Nonvalvular Atrial Fibrillation Patients
	-	MTHFR C677T Polymorphism is Associated with Low Levels of Folic Acid in the InChianti Study
Brohée D	-	New Mutation Inducing a von Willebrand 2A Disease
Brohee D	-	Circulating Platelet-Monocyte Complexes Are Inversely Correlated with Serum Apo-A Levels
Brohult J	-	The Expression of von Willebrand Factor Antigen Differ Between Deep Vein Thrombosis and Pulmonary Embolism
Brojer E	-	Lack of Occult HBV Infection in Polish Haemophilia Patients
Brom J	-	Initial Treatment of Patients with Acute Deep-Vein Thrombosis Using 8.000 IU Bid Low-Molecular-Weight Heparin Certoparin – A 24 Months Follow Up
	-	Prophylaxis of Thromboembolic Complications in Acute Ischemic Stroke with the Low Molecular Weight Heparin Certoparin (PROTECT)
	-	Prevention of Venous Thromboembolism with Low-Molecular-Weight Heparin in Patients with Metastatic Breast or Lung Cancer – Results of the TOPIC Studies
Bromberg ME	-	Hic-5 Promotes Endothelial Cell Migration
Broni[cacute] A	-	Factor XIII Val34Leu Polymorphism in Croatian Population
Brons P	-	Platelet Function Analyser Is a Good Alternative for Classical Bleeding Time to Detect von Willebrand Disease and Thrombocytopathy
Brons PPT	-	13 Novel Mutations in the Factor VIII Gene in the Nijmegen Hemophilia A Patient Population
Bronzi C	-	Collagen-Induced Platelet Shape Change Does Not Require Positive Feedback Activators and Is Insensitive to cAMP Elevating Agents
Brooks S	-	A Diagnostic Challenge: Occurrence of Acquired Haemophilia A in Two Patients on Warfarin Therapy
Brooks JM	-	Prevention of Canine Coronary Artery Thrombosis by the von Willebrand Factor Antagonist, GPG290
Brooks SV	-	Evaluation of a Commercial ELISA Based Assay for Factor XIII A
Brophy T	-	A Novel Integrin aIIbb3-Associating Protein in Platelets
Brophy MT	-	The 80+ Hemorrhagic Cohort Study – Rates, Severity and Predictors of Major Hemorrhage in a Cohort of Anticoagulated Atrial Fibrillation Patients
Brophy M	-	Inflammation and Venous Thromboembolism in Hospitalized Medical Patients
Brosstad F	-	Increased Formation of Platelet-derived Microparticles by Heparin
Brotman DJ	-	The Perioperative and Periprocedural Management of Warfarin: The PPMW Study
Brouilette S	-	Increased Levels of Procoagulant Factors Associated with Increased Potential for Thrombin Generation in Patients with Premature Myocardial Infarction
Brouwer JLP	-	Absolute Risk of Arterial Thromboembolism (ATE) Associated with Nephrotic Syndrome. Results from the Coltrane Study
	-	Reduction of Fetal Loss Rate by Anticoagulant Treatment during Pregnancy in Women with Hereditary Deficiency of Antithrombin, Protein C or Protein S Type I. A Prospective Study
Brouwer JLP	-	Risk of Recurrent Venous Thromboembolism (VTE) Associated with Hereditary Deficiencies of Protein C, Protein S and Antithrombin Depends on Cosegregation with Other Thrombophilic Disorders: A Prospective Family Cohort Study
	-	Hereditary Deficiencies of Protein C, Protein S or Antithrombin Are No Risk Factors for Arterial Thromboembolism (ATE). Results from a Large Family-Cohort Study (DESCARTES)
Brouwer JLP	-	Fetal Loss in Hereditary Antithrombin, Protein C and Protein S Deficiencies
	-	Absolute Risk of Venous Thromboembolism (VTE) Associated with Nephrotic Syndrome. Results from the Coltrane Study
Brouwer JLP	-	A Prospective Study to Assess the Absolute Incidence of Venous Thromboembolism (VTE) Associated with Hereditary Deficiencies of Protein C, Protein S and Antithrombin and the Contribution of Cosegregation of Other Thrombophilic Defects
Brouwer JLP	-	Absolute Risk of Venous Thromboembolism (VTE) Associated with Oral Contraceptives in Women with Hereditary Deficiencies Of Protein S, Protein C or Antithrombin Strongly Depends on Cosegregation of Thrombophilic Disorders. A Retrospective Family Cohort Study (DESCARTES)
Brouwer JLP	-	Hereditary Deficiencies of Protein C, Protein S And Antithrombin Protect Against Bleeding During Anticoagulant Treatment. Results from a Family Cohort Study (DESCARTES)
Brouwer JLP	-	Protein C/S Ratio to Identify Protein S Type I Non-Deficient Relatives at High Risk of Venous Thromboembolism (VTE). Results from a Family Cohort Study (DESCARTES)
	-	Effects of Highly Active Antiretroviral Therapy on the Risk of Venous and Arterial Thromboembolism in Male and Female HIV Positive Patients
Brouwer JLP	-	Absolute Risk of Venous Thromboembolism (VTE) Associated with Hereditary Deficiencies of Protein C, Protein S or Antithrombin Strongly Depends on Cosegregation of other Thrombophilic Disorders. A Retrospective Family Cohort Study (DESCARTES)
Brouwer JLP	-	High Risk of Venous Thromboembolism (VTE) Associated with Oral Contraceptives in Women with Hereditary Deficiencies of Protein S, Protein C or Antithrombin Is Due to Acceleration Rather Than Overall Increased Risk. A Retrospective Family Cohort Study (DESCARTES)
	-	Protein C/S Ratio Improves Accuracy to Identify Hereditary Protein S Deficiency Type I. Results from a Family Cohort Study (DESCARTES)
Browett PJ	-	ZPI Gene Mutations and Myocardial Infarction
Brown L	-	Molecular Characterization of a 4.4 Mbp Deletion of the X Chromosome in a Male with Hemophilia B
Brown C	-	Molecular Characterization of a 4.4 Mbp Deletion of the X Chromosome in a Male with Hemophilia B
Brown RC	-	Anti-phospholipid Antibody Syndrome in the Neonatal Period: Report of a Rare Case
Brown C	-	Understanding the Genotype/Phenotype Link in Type 1 von Willebrand Disease (VWD): Results from The Canadian Type 1 VWD Study
Brown MA	-	Precursors of Novel Gla-Containing Conotoxins Contain a Carboxy-Terminal Recognition Site that Directs g-Carboxylation by g-Glutamyl Carboxylase
Brown SA	-	Evaluation of a Commercial ELISA Based Assay for Factor XIII A
Brown S	-	The Platelet Actin Cytoskeleton Dynamically Reorganizes into Podosomes Upon Cell Adhesion. Identification of a Novel Actin-rich Adhesive Structure in Human Platelets
Brown C	-	The Mutational Spectrum of Type 1 Von Willebrand Disease (VWD): Results from the Canadian Type 1 VWD Study
Brown S	-	A UK Survey of Prophylaxis in Paediatric Patients with Haemophilia
Brown C	-	A Pilot Study of a DNA Microarray-Based Approach for the Screening of Mutations in Hemophilia A
Brown SA	-	Investigation of Relationship between ADAMTS-13, Von Willebrand Factor Antigen and Collagen-Binding Activity in Patients with Type 1 Von Willebrand Disease
	-	A Diagnostic Challenge: Occurrence of Acquired Haemophilia A in Two Patients on Warfarin Therapy
	-	Investigation of Relationship of von Willebrand Factor Antigen Clearance with ADAMTS-13 Activity and Tyr1584Cys Polymorphism in Type 1 von Willebrand Disease
Brown K	-	Prothrombin Binding to Phospholipid Membranes – A Proposed Mechanism
Brown SA	-	Early FVIII Exposure and Subsequent Inhibitor Development in Children with Severe Haemophilia A
Brownlow SL	-	TRPC Associations in Human Platelets
Brox J	-	The Eskimo Diet: More Than Omega-3 Fatty Acids
	-	Interleukin-8 (IL-8) Generation in Whole Blood Is Related to Markers of Atherosclerosis
Broze G	-	Role of Gamma-Carboxyglutamic Acid (Gla) and First Epidermal Growth Factor (EGF1)-Like Domains of Factor IX (FIX) in Physiologic Coagulation
Broze Jr GJ	-	Immunohistochemical Localization of Protein Z (ZP) and Protein Z-Dependent Protease Inhibitor (ZPI) in Situ in Human Malignant Tumors
Brozek J	-	Simvastatin Given for 3 Days Can Inhibit Thrombin Generation and Activation of Factor V, and Enhance Factor Va Inactivation in Hypercholesterolemic Patients
Brueckmann M	-	Drotregocin Alfa (Activated) Down-Regulates RANTES in Peripheral Blood Mononuclear Cells of Septic Patients In Vivo
Bruel A	-	Strong Antithrombotic Effect of the Type III Collagen-Related Octapeptide (KOGEOGPK) in the Mouse
Brugge JM	-	Thrombin Generation and Activated Protein C Resistance in Factor V Leiden Pseudo-homozygous Patients
Bruggeman LW	-	Coagulation Factors VIIa and Xa Promote Apoptosis in Human Tumor Cells in Association with CREB Activation
Brüggemann LW	-	Effect of Modified Normothrombotic Heparin on Cancer Progression and Metastasis
Brugger Andersen T	-	Plasma Concentrations of Soluble Fibrin, D-dimer, Myeloperoxidase and Pregnancy Associated Plasma Protein A before and after Treatment with PCI or Thrombolysis for Acute Myocardial Infarction
Brügger-Andersen T	-	Activated Factor XII Provides Better Short-term Prognostic Information for a Subsequent Troponin-T Positive Event than other Biomarkers in Patients with Myocardial Infarction
Brummel K	-	Anticoagulant Effects of Statins and Angiotensin-Converting Enzyme Inhibitors in Stable Patients with Coronary Artery Disease: Results of a Randomized Double Blind Study
Brummel-Ziedens KE	-	What All That Thrombin Is for
Brummel-Ziedins KE	-	The Influence of Bivalirudin on Tissue Factor-Initiated Thrombin Generation
Brummel-Ziedins K	-	Simvastatin Given for 3 Days Can Inhibit Thrombin Generation and Activation of Factor V, and Enhance Factor Va Inactivation in Hypercholesterolemic Patients
Brun NC	-	Effects of Recombinant Activated Factor VII on Perilesional Oedema in Patients with Acute Intracerebral Haemorrhage
	-	No Influence of Antiplatelet Therapy on the Outcome of Acute Intracerebral Haemorrhage Treated with Recombinant Activated Factor VII
Brunet A	-	The Thrombin-Thrombomodulin Complex Activates Nitric Oxide Synthase 3 through Calmodulin Kinase II and Phosphoinositide 3-kinase Signalling
Brunet P	-	Endothelial Microparticle Elevation in Uremia: A New Aspect of Endothelial Dysfunction Related to Uremic Toxins
Bruneval P	-	Low Molecular Weight Fucoidan Is More Effective Than Low Molecular Weight Heparin in Preventing Arterial Thrombosis in a Rabbit Model
Bruni F	-	Modified Antiplatelet Action of Atorvastatin in 3'UTR/T LOX-1 Polymorphism Carriers
Brunner P	-	Inhibition of the Transcription Factor EGR-1 Significantly Reduces Neointima Formation in a Rabbit Iliac Artery Angioplasty Model
	-	Antiapoptotic Activity of Vascular Endothelial Growth Factor (VEGF) Is also Mediated by VEGF Induced Pro-urokinase (Pro-uPA) Activation
Brunsch H	-	The Factor VII Activating Protease (FSAP) Is an Inhibitor of Neointimal Lesion Formation. Comparison with the Marburg I SNP (G511E) of FSAP
Brusasco C	-	Determinants of Mortality in Cerebral Hemorrhage Patients on Antithrombotic Treatment: Prospective Evaluation in the Italian Emergency Departments of a Multicentric Cohort of 1071 Patients
Brusi C	-	The D-dimer (DD) Test to Establish the Duration of Anticoagulation after a First Unprovoked Episode of Venous Thromboembolism (VTE); the Prospective Randomized ‘Prolong’ Study on behalf of the Italian Federation of Anticoagulation Clinics (FCSA)
Brusky RM	-	The Incidence and Outcome of Intracranial Hemorrhage in Newborns with Hemophilia: Analysis of the Nationwide Inpatient Sample (NIS) Database
Bryl E	-	Expression of the Death Receptor Fas (CD95) on Peripheral T Lymphocytes in Correlation with Selected Clotting System Parameters in Non-Small Cell Lung Cancer
	-	Correlation Between Selected cloTting Factors Parameters and Apoptosis of Peripheral T Lymphocytes in Non-Small Cell Lung Cancer
Bryniarski L	-	Anticoagulant Effects of Statins and Angiotensin-Converting Enzyme Inhibitors in Stable Patients with Coronary Artery Disease: Results of a Randomized Double Blind Study
Brynildsrud T	-	Afinion™ AS100 Analyzer – a Multi-Assay System Including a New PT-INR Test
Bryszewska M	-	Increased Aspirin Hydrolysis in Plasma of Patients with Type 2 Diabetes Mellitus: A New Mechanism of ‘Aspirin Resistance’?
Brzezinska-Kolarz B	-	Kinetics of Thrombin Formation at the Site of Microvascular Injury: Effects of Coagulation Factors and Oral Anticoagulation
Brzezinska-Kolarz B	-	Complementary Antithrombotic Effects of Aspirin and Clopidogrel Based on PlA1/A2 Glycoprotein IIIa Polymorphism
Brzezinska-Kolarz B	-	Factor VIII Levels and Blood Coagulation in Patients on Long-Term Oral Anticoagulation (OA)
Brzosko S	-	Relationship Between Extrinsic Coagulation Pathway Activation and Metalloproteinase-2/TIMPs System in Hemodialysis Patients
Buccholz N	-	Normal VWF Synthesis and Processing in Patients with Decreased Plasma Survival of C6536T Variant VWF
Bucciarelli T	-	Determinants of Platelet Activation in Alzheimer's Disease
Bucciarelli P	-	Risk Factors for Thrombophilia in Extra-Hepatic Portal Vein Obstruction
	-	Low Protein Z Levels and Venous Thrombosis
Buchacher A	-	Combinatorial Peptides Directed to Inhibitory Antibodies against Human Blood Clotting Factor VIII
Buchanan GR	-	Management of Asymptomatic Catheter-related Thrombosis in Children with Acute Lymphoblastic Leukemia (ALL): A Survey of Clinical Practice
Buckland RJ	-	Incomplete P2Y12 Receptor Blockade by Clopidogrel Is Not Due to the Presence of an Internal Pool of P2Y12 Receptors
	-	Utility of a Whole-Blood Single-Platelet Counting Assay in Monitoring the Effects of Tirofiban
Buckley CD	-	Regulation of Spreading in PECAM-1 Knock-Out Mouse Platelets
Buczko W	-	Angiotensin 1–9 (Ang-1-9), Similarly to Angiotensin II (Ang II), Increases Blood Pressure and Enhances Thrombosis in Hypertensive Rats
Buczma A	-	Severe Hemophilia in Poland – Focus on Hemophilic Arthropathy
Budde U	-	A Reduced VWF to FVIII Binding Capacity is not Uncommon in Patients With Type 1 Von Willebrand Disease: Results From the MCMDM-1VWD Study
	-	Gene Conversions Are a Common Cause of von Willebrand Disease
	-	Mutation Profile in Patients Diagnosed with Type 1 von Willebrand Disease in the European Study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD)
	-	Cysteine Mutations in the von Willebrand Factor D3 Domain Correlate with Multimerization Defects in Patients Previously Diagnosed with von Willebrand Disease Type 1 in Patients Entered in the European Multicentre Study MCMDM-1VWD
	-	Linkage Analysis of von Willebrand Disease Type 1 Phenotype, von Willebrand Factor Levels and Bleeding Symptoms with Von Willebrand Factor Gene Locus in the European Multicenter MCMDM-1VWD Study
	-	Responsiveness to Desmopressin: Influence of Genotype in Patients Diagnosed with Type 1 von Willebrand Disease in the European Study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD
	-	Abnormal Multimeric Pattern Is Not Associated with Increased Bleeding Symptoms in Index Cases of Families with Type 1 VWD. Results from the EU MCMDM-1 VWD Study
	-	Two Novel Type 1 Von Willebrand Disease Causing Mutations (G160W and N166I) in the Von Willebrand Factor Propeptide, Identified in the European Study MCMDM-1VWD, Are Responsible for Multimerization And Secretion Defects
	-	Analysis of Bleeding Score in Type 1 VWD Families in the MCMDM-1 Study
	-	Collagen Binding (VWF : CB) Is Less Sensitive Than Ristocetin Cofactor Activity (VWF : RCo) in Suggesting Von Willebrand Factor (VWF) Molecular Defects in Patients with Von Willebrand Disease Type 1: Results From the European Multicenter MCMDM-1VWD Study
	-	In vitro Expression of Ten Missense Mutations in the VWF C-Terminal Domain Identified in Patients Diagnosed with Type 1 VWD: Results from the MCMDM-1VWD Study
	-	A Baltic Origin of the Common ADAMTS13 Mutation 4143insA
	-	Assay of the von Willebrand Factor Propeptide (VWFpp) to Identify Type 1 von Willebrand Disease (VWD) Patients with a Decreased von Willebrand Factor (VWF) Survival Phenotype
	-	Association of FVIII/Von Willebrand Factor Measurements and PFA-100® with Bleeding Score in Type 1 Von Willebrand Disease (VWD) Families. The MCMDM-1 Study
	-	Tyr1605-Met1606 Flanking the Von Willebrand Factor Cleavage Site Are Not Required for Cleavage of VWF by ADAMTS13
	-	The Factor VIII/von Willebrand Factor Antigen (FVIII/VWF : Ag) Ratio in Determining VWF Defects in Patients with von Willebrand Disease Type 1: Results from the European Multicenter MCMDM-1VWD Study
	-	Multimer Pattern in Patients Diagnosed with Type 1 von Willebrand Disease in the European Study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD)
	-	The Incidence and Penetrance of Common VWF Gene Mutations in a Cohort of Type 1 VWD Patients: Results from the EU Funded MCMDM-1VWD Project
Budihna MV	-	New Direct Thrombin Inhibitors Build on Azaphenylalanine Scaffold – Antithrombotic Effect in Two Rat Venous Thrombosis Models
Buehler L	-	Isolation, Characterization and Angiogenic Potential of Human Mesenchymal Stem Cell-Derived Endothelial-Like Progenitor Cells
Buelens K	-	Construction and Characterization of MA-T94H3 Derivatives, a TAFI Neutralizing Antibody
Buensuceso C	-	Integrin As Scaffold
Bühler B	-	The Role of Platelet Factor 4 and the Use of Dextran Sulfate in Anti Factor Xa Assays: Overestimation of Anticoagulant Activity in LMWH Therapy?
Buil A	-	A Genome Search for Genetic Determinants That Influence Plasma Fibrinogen Levels
Bulabois5 CE	-	Evolution of Antithrombin (AT) and Fibrinogen (Fg) Levels during Induction Chemotherapy with L-asparaginase (Asp) in Adult Patients with Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL). Clinical Outcomes and Use of Coagulation Supportive Treatments: The CAPELAL Study
Bulanov A	-	Effects of Plasma Dilution with Crystalloid or Colloid Solutions on Blood Coagulation
Buliková A	-	Project HemIS (Haemophilia – Information System): Multicentric Information System of Patients with Haemophilia
Bullano MF	-	Monitoring International Normalized Ratio (INR) in Patients with Chronic Non-Valvular Atrial Fibrillation: Relationships between INR and Adverse Outcomes?
Büller HR	-	Coagulation in Aviation: Activation of the Coagulation System During Air Travel (The WRIGHT Volunteers Study)
Buller HR	-	Interleukin-10, Interleukin-6, and Interferon-g in Advanced Malignancy: Prognostic Relevance and Impact of Low-Molecular-Weight Heparin Administration
Büller H	-	Value of D-dimer, for the Exclusion of Deep Venous Thrombosis, in Different Pre-test Clinical Probability Categories
Büller HR	-	Thromboembolic and Bleeding Complications during Non-cardiac Surgery in Patients with Mechanical Heart Valves
Buller HR	-	Pentraxin 3 in Patients with Pulmonary Embolism
	-	Alternative Clinical Diagnoses with Spiral CT in Patients with Suspected Pulmonary Embolism
Büller HR	-	D-Dimer Test in Cancer Patients with Suspected Acute Pulmonary Embolism
	-	Effect of Modified Normothrombotic Heparin on Cancer Progression and Metastasis
	-	Incidence of Venous and Arterial Thromboembolism in Asymptomatic Carriers of the Prothrombin 20210A Mutation – A Prospective Cohort Study
	-	Defining Subclinical Phenotypes for Venous Thromboembolism through Measurement of a Hypercoagulable State in Thrombophilic Families
Buller HR	-	Outcomes in Obese Patients of Pulmonary Embolism (PE) and Deep Vein Thrombosis (DVT) Treatment with Fondaparinux or (LMW) Heparins: The Matisse Trials
Büller H	-	What Is the Real Contribution of Standardized Pre-test Clinical Probability Scores and D-dimer Assays to the Diagnostic Management of Deep Vein Thrombosis? Systematic Review of Clinical Outcome Studies
Buller HR	-	Clinical Usefulness of Prothrombin Fragment 1+2 in Patients with Suspected Pulmonary Embolism
Büller HR	-	The Contribution of Cosegregation to the Absolute Risk of Venous Thromboembolism (VTE) in Relatives with Either the Prothrombin G20210A Mutation, High Factor VIII : C Levels or Mild Hyperhomocysteinemia
	-	Effects of Clopidogrel on the Rebound Hypercoagulable State in Acute Coronary Syndromes (ACS) Patients after Heparin Discontinuation
Buller HR	-	The Distribution Of Central, Segmental And Sub-Segmental Pulmonary Emboli In Multi- And Single-Row Helical CT
Büller HR	-	Search for Novel Genetic Risk Factors in Venous Thromboembolism: Design of a Family Study
	-	Brain Natriuretic Peptide in Hemodynamically Stable Acute Pulmonary Embolism
	-	Hereditary Thrombophilia is not a Risk Factor for Idiopathic Retinal Vein Thrombosis
	-	Incidence of Deep Vein Thrombosis after Knee Arthroscopy without Thromboprophylaxis
	-	A Prospective Cohort Study of Asymptomatic Individuals with Elevated Factor VIII : c to Determine the Absolute Incidence of Venous and Arterial Thromboembolism
	-	Endotoxemia Induces Factor VIII-mediated Resistance to Activated Protein C in Healthy Humans
	-	The Prognostic Value of the D-Dimer Test in Cancer Patients Treated with and without Low-Molecular-Weight Heparin
	-	Absolute Risk of Venous and Arterial Thromboembolism Associated with Mild Hyperhomocysteinemia. Results from a Retrospective Family Cohort Study
	-	The Role of PAI-1 Deficiency and a Reduced Capacity to Generate Activated Protein C on Coagulation Activation and Fibrin Formation during Murine Influenza Pneumonia
	-	Naturally Occurring Acute Viral Respiratory Tract Infections in Elderly Patient Results in Increased von Willebrand and Enhanced Fibrinolysis
	-	Prognostic Value of Echocardiography and Chest Computed Tomography in Patients with Pulmonary Embolism
	-	Incidence of Venous Thromboembolism Among Dutch Airline Pilots
	-	Comparison of Protein Profile Analysis in Patients with and without a History of Venous Thromboembolism: A Pilot Study
Buller HR	-	C-reactive Protein in Combination with Clinical Decision Rule and D-Dimer to Safely Rule out Pulmonary Embolism
	-	Reliability and Interobserver Variability of the Simplify® D-Dimer Assay for Detecting D-Dimers in Capillary Blood
Bullinger M	-	Quality of Life in Patients with Haemophilia – An European Comparison Study (ESCHQoL)
Bullorsky E	-	Failure of the Outpatient Bleeding Risk Index to Predict Major Bleeding in Older Patients Receiving Coumarin for Atrial Fibrillation
	-	Validation of a Clinical Score (CS) Plus D-Dimer (DDi) Combination As a Diagnostic Strategy to Exclude Pulmonary Embolism (PE)
	-	Neonatal DIC by Enterovirus. Favorable Outcome with Maternal Plasma Transfusion
Bullorsy EO	-	Fibrinolytic Peritoneal Response to Laparoscopic Surgery
Bülow R	-	Plasma Lipids and Lipoproteins in Healthy Subjects are Closely Related to INR
Bultelle F	-	Gene Expression Comparison Between Monocytes in Culture and Atherosclerotic Laser Microdissected Resident Macrophages
	-	Macrophage Gene Expression Appears to Differ between AGE and OxLDL Stimulation
Bumbal J	-	Changes of Coagulation after Single i.v. Bolus 0.75 mg Per kg of Low Molecular Weight Heparin Enoxaparin During PCI – A Pharmacokinetic Study
Bunjevacki G	-	Pediatric Thrombosis
Buonanno FS	-	Massive Sinus Thrombosis in a Six-Year-Old Girl: Acute Management and Identification of a Possible New Hypercoagulable State
Burfeind P	-	Coagulation Factor XII is Essential for Arterial Thrombus Formation in Vivo
	-	Heparin-Binding Protein Increases Vascular Permeability by Bradykinin Release: A Novel Link Between Neutrophils and Vascular Inflammation
Burggraaf J	-	Comparative Effects of a Contraceptive Vaginal Ring Delivering Nestorone® and Ethinyl Estradiol, and a Combined Oral Contraceptive Containing Levonorgestrel on Risk of Venous Thromboembolism Evaluated through Haemostasis Variables and Sex Hormone Binding Globulin
	-	Comparative Effects of a Contraceptive Vaginal Ring Delivering Nestorone® and Ethinyl Estradiol, and a Combined Oral Contraceptive Containing Levonorgestrel, on Lipids and Inflammation Markers of Arterial Disease
Burghaus B	-	Elevated Alpha 1-Antitrypsin Is a Risk Factor for Arterial Ischemic Stroke in Childhood
Burlacu A	-	Cardiomyogenic Differentiation Induced by in vitro Manipulation of Adult Stem Cells
Burman JF	-	Thrombin Potential in Severe Haemophilia A and B Patients
	-	Can the Rotem® Predict Post-Operative Bleeding and Appropriate Treatment after Cardiac Surgery?
	-	Following Cardiac Surgery Patients Who Develop Biphasic Waveforms as Seen on the MDA-180 Automated Coagulation Analyser Have Increased Thrombin Potential in-vitro. This Is Partly due to Tissue Factor Present in the CRP-VLDL Complex
Burman H	-	Robustness Testing of OPTIVATE® Intermediate Purification Stages
Burman JF	-	Aspirin Resistance: Platelet Resistance not Non-Compliance
Burnand K	-	Adenovirus Urokinase (uPA) Gene Transfection Mediates Monocyte Fibrinolysis
	-	Monocyte Recruitment and Increased Urokinase (uPA) Activity are Important for Thrombus Resolution
Burnand KG	-	Adenovirus-Mediated VEGF Gene Therapy Enhances Venous Thrombus Resolution
Burner J	-	Lack of Correlation between OD Value of Elisa and Clinical Thrombosis in Patients with Heparin Induced Thrombocytopenia (HIT)
Burnier L	-	Mice Lacking Gas6 are Protected from Graft-Versus-Host Disease in the Liver Due to a Reduced Activation of the Endothelium
	-	Plasma Levels of Gas6 and its Soluble Receptors In Severe Sepsis: Diagnostic and Prognostic Implications
Burnouf T	-	Orientia Tsutsugamushi Infection (scrub typhus) Is Associated with an Infraclinical Activation of the Coagulation System But Not with an Activation of Endothelial Cells
Burns T	-	A Missense Mutation in Exon 28 (C4120T) of the Von Willebrand Factor Gene is the Cause for Von Willebrand Disease in a Large Amish Pedigree
Burns AR	-	Adhesion Molecules and Leukocyte Migration in the Context of Corneal Wound Healing
Burstein C	-	Cardiovascular Interventions and Surgery in Patients with Haemophilia and Von Willebrand Disease
Burysek L	-	The Annexin II Heterotetramer is a Receptor for the Plasmin-Induced Signaling in Human Peripheral Monocytes
Bush L	-	Prolonged Anticoagulation and Sustained Therapeutic Endogenous Activated Protein C (APC) Levels during Protein C Activation in Primates by a Thrombin Variant
Bussel JB	-	Anti-D Compared to IVIg for the Treatment of Immune Thrombocytopenic Purpura: A Systematic Review
Bussel J	-	An Open-Label Study Evaluating the Safety and Efficacy of Long-Term Dosing of AMG 531 in Thrombocytopenic Subjects with Immune (Idiopathic) Thrombocytopenic Purpura
Busson J	-	Effect Of BAY 59-7939 – A Novel, Oral, Direct Factor Xa Inhibitor – on Clot-Bound Factor Xa Activity in vitro
Bussotti M	-	Impaired Bradykinin Response to Ischemia and Exercise in Patients with Mild Congestive Heart Failure During Angiotensin-Converting Enzyme Treatment. Relationships with Endothelial Function, Coagulation and Inflammation
Butenas S	-	Activity and Content of Factor VIII in Various Factor VIII Products
Butenas S	-	What All That Thrombin Is for
	-	Quantitation of FVIII Antigen in Human Plasma
Butenas S	-	The Influence of Bivalirudin on Tissue Factor-Initiated Thrombin Generation
	-	Synergistic Antagonists for Hemophilia Treatment
Butler J	-	Evaluation of Diamed ID-PaGIA Heparin/PF4 Antibody Test for the Diagnosis Of HITTS
Butler J	-	An Evaluation of the New ACL TOP Coagulation Autoanalyser
	-	The Development of a Protocol for Lepirudin Therapy Monitoring
Butler WE	-	Massive Sinus Thrombosis in a Six-Year-Old Girl: Acute Management and Identification of a Possible New Hypercoagulable State
Butt W	-	Developmental Haemostasis and Response to Heparin Therapy in Children
	-	Tissue Factor Pathway Inhibitor (TFPI) during Heparin Therapy in the Paediatric Intensive Care Unit (PICU)
Buurman W	-	Low Molecular Weight Heparin Attenuates Multiorgan Failure in DIC
Buyearu N	-	Factor V Leiden and Prothrombin G20210A Mutations in Children with Cerebral Palsy
Byams VR	-	Quality of Life (QoL) Evaluation in Women with Menorrhagia and Inherited Bleeding Disorders
Bydlowski SP	-	Heparin Induced Thrombocytopenia Type II In Cardiac Hemodialysis Brazilian Patients
Bykowska K	-	Polymorphisms C807T, G873A and G1648A of Platelet Glycoprotein Ia in Young Adults with Ischemic Stroke
Bykowska K	-	Inherited Thrombophilia (IT) in Patients with Chronic Venous Ulceration (CVU)
Bylock A	-	Persistently Reduced D-dimer Levels by the Oral Direct Thrombin Inhibitor Ximelagatran Indicate Reduced Risk of New Ischemic Events after Myocardial Infarction
	-	ASA and NSAIDs with Melagatran/Ximelagatran or Enoxaparin Do NOT Increase Bleeding in Patients Undergoing Joint Replacement Surgery. The METHRO III Study
Byrne S	-	A Multi-Dose Pharmacokinetic Study of Dalteparin in Hemodialysis Patients
Byrne E	-	Preparation of Reference Materials for the Genetic Diagnosis of Thrombophilia